To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CSNK1ETABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
655 supporting clones for gene CSNK1E back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA283493 corpus callosum CSNK1E.a 1 to 548 2 to 549   tiling clone, capped   548/548
(100 %)
0 diff
(100 %id)
BX374792 Neuroblastoma Cot 25-normalized CSNK1E.a 92 to 1126 1 to 1026   tiling clone,   1026/1081
(94 %)
19 diff
(98.3 %id)
BX348062 Placenta Cot 25-normalized CSNK1E.a 942 to 1422 1 to 481   tiling clone,   481/481
(100 %)
25 diff
(94.9 %id)
BU194639 melanotic melanoma, skin CSNK1E.a 1000 to 1758 1 to 770   AAA   770/883
(87 %)
27 diff
(97.0 %id)
BM550032 astrocytoma grade IV, cell line, brain CSNK1E.a 1071 to 1867 844 to 42   tiling clone, Submitted on the opposite strand 803/1075
(74 %)
11 diff
(99.0 %id)
CB241465 Human Lung Epithelial cells, lung CSNK1E.a 1120 to 1857 736 to 1   tiling clone,   736/736
(100 %)
5 diff
(99.4 %id)
AA112442 Pancreas CSNK1E.a 1161 to 1428 1 to 275       275/333
(82 %)
13 diff
(96.1 %id)
AI921530 poorly differentiated adenocarcinoma withsignet ring cell features, stomach CSNK1E.a 1215 to 1839 627 to 6       622/750
(82 %)
17 diff
(97.8 %id)
BM761879 lymph node, stomach CSNK1E.a 1219 to 1643 1 to 425       425/425
(100 %)
0 diff
(100 %id)
BM840668 lymph node, stomach CSNK1E.a 1219 to 1653 1 to 435       435/435
(100 %)
0 diff
(100 %id)
BE140537 head_neck CSNK1E.a 1247 to 1439 1 to 193       193/193
(100 %)
1 diff
(99.5 %id)
BM556941 melanotic melanoma, skin CSNK1E.a 1284 to 1839 1 to 556   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 556/556
(100 %)
0 diff
(100 %id)
CR999001 T-Lymphocytes CSNK1E.a 1285 to 1839 1 to 555   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 555/555
(100 %)
0 diff
(100 %id)
BE140538 head_neck CSNK1E.a 1320 to 1451 132 to 1     Submitted on the opposite strand 132/132
(100 %)
1 diff
(99.3 %id)
AI861929 colon, colon tumor, RER+ CSNK1E.a 1380 to 1850 471 to 1       471/471
(100 %)
5 diff
(99.0 %id)
AI090109 uterus CSNK1E.a 1391 to 1839 449 to 1       449/449
(100 %)
0 diff
(100 %id)
AA113121 Pancreas CSNK1E.a 1419 to 1842 422 to 1       422/423
(99 %)
6 diff
(98.6 %id)
CR591261 Neuroblastoma Cot 50-normalized CSNK1E.b 1 to 2048 1 to 2048 exact tiling clone,   2048/2048
(100 %)
0 diff
(100 %id)
AV721028 hypothalamus CSNK1E.b 1658 to 2196 17 to 554   tiling clone,   538/624
(86 %)
14 diff
(97.8 %id)
CR594270 Placenta Cot 25-normalized CSNK1E.c 1 to 1323 1 to 1323 exact tiling clone,   1323/1323
(100 %)
0 diff
(100 %id)
CR590991 HeLa cells Cot 25-normalized CSNK1E.c 945 to 1949 1 to 1005   tiling clone,   1005/1005
(100 %)
0 diff
(100 %id)
BX328845   CSNK1E.c 945 to 1857 1 to 909       909/909
(100 %)
5 diff
(99.5 %id)
BX341526   CSNK1E.c 945 to 1859 1 to 915       915/915
(100 %)
0 diff
(100 %id)
BX352404   CSNK1E.c 1130 to 1949 819 to 1       819/897
(91 %)
14 diff
(98.5 %id)
DB558806 hypothalamus CSNK1E.c 1431 to 1874 1 to 443     Submitted on the opposite strand 443/443
(100 %)
10 diff
(97.8 %id)
AA935456 metastatic prostate bone lesion CSNK1E.c 1528 to 1863 1 to 336       336/336
(100 %)
5 diff
(98.6 %id)
CR619665 fetal brain CSNK1E.d 1 to 1603 1 to 1603 exact tiling clone,   1603/1603
(100 %)
0 diff
(100 %id)
CR592492 Neuroblastoma Cot 25-normalized CSNK1E.d 34 to 1601 1 to 1568 exact     1568/1568
(100 %)
0 diff
(100 %id)
CR599035 Neuroblastoma Cot 25-normalized CSNK1E.d 34 to 1575 1 to 1542       1542/1542
(100 %)
0 diff
(100 %id)
BX340105 Placenta Cot 25-normalized CSNK1E.d 39 to 1017 1 to 967       967/999
(96 %)
37 diff
(96.3 %id)
BU182187 eye, retinoblastoma CSNK1E.d 48 to 476 1 to 431       431/961
(44 %)
13 diff
(98.7 %id)
BX394692 Neuroblastoma Cot 25-normalized CSNK1E.d 49 to 921 15 to 883   fully sequenced,   869/883
(98 %)
2 diff
(99.8 %id)
BX400793   CSNK1E.d 52 to 957 21 to 919       899/919
(97 %)
3 diff
(99.7 %id)
CR622296 T cells (Jurkat cell line) Cot10-normalized CSNK1E.d 53 to 1546 1 to 1494       1494/1494
(100 %)
0 diff
(100 %id)
BX346456   CSNK1E.d 53 to 1050 1 to 988       985/989
(99 %)
30 diff
(97.0 %id)
BX383597   CSNK1E.d 53 to 596 1 to 543       543/543
(100 %)
1 diff
(99.9 %id)
CN481076 eye CSNK1E.d 53 to 174 1 to 122       122/122
(100 %)
2 diff
(98.4 %id)
BX332714 Neuroblastoma Cot 25-normalized CSNK1E.d 54 to 921 21 to 882   fully sequenced,   862/882
(97 %)
5 diff
(99.5 %id)
BX449376 brain, fetal brain CSNK1E.d 60 to 890 1 to 830       830/830
(100 %)
16 diff
(98.1 %id)
BX341515   CSNK1E.d 62 to 1010 1 to 945       945/945
(100 %)
9 diff
(99.1 %id)
BX371295   CSNK1E.d 62 to 1020 1 to 957       957/957
(100 %)
10 diff
(99.0 %id)
BX460688 brain, fetal brain CSNK1E.d 63 to 890 1 to 830       830/830
(100 %)
7 diff
(99.2 %id)
BM807429 brain, hippocampus CSNK1E.d 64 to 518 70 to 521       452/1366
(33 %)
10 diff
(99.3 %id)
CB961546 placenta, pre-eclamptic placenta CSNK1E.d 65 to 791 27 to 757       731/802
(91 %)
10 diff
(98.8 %id)
CB959590 Human Placenta, placenta CSNK1E.d 65 to 723 27 to 691       665/778
(85 %)
14 diff
(98.3 %id)
CB990227 Human Placenta, placenta CSNK1E.d 65 to 512 27 to 472       446/889
(50 %)
5 diff
(99.5 %id)
CF594072 Human Placenta, placenta CSNK1E.d 65 to 843 28 to 813       786/939
(83 %)
25 diff
(97.4 %id)
NM_152221.2   CSNK1E.d 65 to 2855 1 to 2791 exact RefSeq, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 2791/2791
(100 %)
0 diff
(100 %id)
BM473809 melanotic melanoma, skin CSNK1E.d 66 to 551 1 to 489       489/1421
(34 %)
7 diff
(99.6 %id)
BX375605 Neuroblastoma Cot 25-normalized CSNK1E.d 70 to 881 1 to 810       810/810
(100 %)
69 diff
(91.5 %id)
DR002175 fetal brain CSNK1E.d 75 to 631 6 to 559       554/559
(99 %)
1 diff
(99.9 %id)
BX420318 brain, fetal brain CSNK1E.d 78 to 1014 1 to 936       936/936
(100 %)
3 diff
(99.7 %id)
BQ642398 lymph, lymphoma, cell line CSNK1E.d 81 to 823 1 to 753       754/993
(75 %)
24 diff
(97.6 %id)
CR997825 T-Lymphocytes CSNK1E.d 84 to 553 1 to 471       471/471
(100 %)
5 diff
(99.0 %id)
BM802777 embryonal carcinoma, cell line, testis CSNK1E.d 85 to 789 1 to 705       705/1156
(60 %)
24 diff
(98.0 %id)
BQ434269 melanotic melanoma, skin CSNK1E.d 86 to 891 16 to 822       807/884
(91 %)
30 diff
(96.7 %id)
CN368313 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CSNK1E.d 87 to 465 1 to 380       380/380
(100 %)
1 diff
(99.8 %id)
BQ943755 carcinoma, cell line, Prostate CSNK1E.d 89 to 402 1 to 319       319/957
(33 %)
7 diff
(99.3 %id)
BX404525 neuroblastoma CSNK1E.d 93 to 1058 1 to 957       957/957
(100 %)
19 diff
(98.1 %id)
BM450099 melanotic melanoma, skin CSNK1E.d 93 to 403 1 to 314       314/1429
(21 %)
7 diff
(99.6 %id)
CR978234 T-Lymphocytes CSNK1E.d 102 to 705 1 to 605       605/606
(99 %)
2 diff
(99.7 %id)
BQ049417 lymph, lymphoma, cell line CSNK1E.d 107 to 842 1 to 755       755/1025
(73 %)
23 diff
(97.8 %id)
CR614988 Placenta Cot 25-normalized CSNK1E.d 119 to 1608 1 to 1490 exact     1490/1490
(100 %)
0 diff
(100 %id)
CR601968 fetal brain CSNK1E.d 124 to 1629 1 to 1506 exact tiling clone, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 1506/1506
(100 %)
0 diff
(100 %id)
BX428291 brain, fetal brain CSNK1E.d 124 to 1050 1 to 917       917/924
(99 %)
16 diff
(98.3 %id)
BX441443 brain, fetal brain CSNK1E.d 124 to 1094 1 to 968       968/968
(100 %)
1 diff
(99.9 %id)
CV571608 cornea, eye CSNK1E.d 124 to 680 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BQ230576 melanotic melanoma, skin CSNK1E.d 125 to 857 1 to 735       735/925
(79 %)
10 diff
(99.0 %id)
CX786570 human embryonic stem cells CSNK1E.d 126 to 901 1 to 776       776/776
(100 %)
0 diff
(100 %id)
DB499764 hypothalamus CSNK1E.d 139 to 641 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
CN368317 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CSNK1E.d 143 to 427 1 to 285       285/285
(100 %)
0 diff
(100 %id)
BM547701 brain, hippocampus CSNK1E.d 144 to 881 1 to 754       754/1208
(62 %)
41 diff
(96.7 %id)
CR618321 fetal brain CSNK1E.d 147 to 1608 1 to 1462 exact     1462/1462
(100 %)
0 diff
(100 %id)
BX460606 brain, fetal brain CSNK1E.d 147 to 1085 1 to 939       939/939
(100 %)
8 diff
(99.2 %id)
BQ067211 pooled brain, lung, testis CSNK1E.d 150 to 901 25 to 786       762/1243
(61 %)
13 diff
(99.0 %id)
BU902990 leiomyosarcoma, uterus CSNK1E.d 165 to 885 1 to 737       737/857
(85 %)
24 diff
(97.2 %id)
BQ431946 melanotic melanoma, skin CSNK1E.d 167 to 886 34 to 757       724/879
(82 %)
5 diff
(99.5 %id)
AK223498 adipose tissue CSNK1E.d 168 to 1629 1 to 1462 F254C AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 1462/1462
(100 %)
1 diff
(100.0 %id)
BX324698 Placenta Cot 25-normalized CSNK1E.d 171 to 991 52 to 870   fully sequenced,   819/870
(94 %)
1 diff
(99.9 %id)
BF726123 eye, lens CSNK1E.d 172 to 737 1 to 566     Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 566/566
(100 %)
0 diff
(100 %id)
BM556452 amelanotic melanoma, cell line, skin CSNK1E.d 172 to 792 30 to 645       616/755
(81 %)
12 diff
(98.5 %id)
BM554321 amelanotic melanoma, cell line, skin CSNK1E.d 172 to 1195 24 to 1061       1038/1166
(89 %)
25 diff
(97.9 %id)
BX428623 brain, fetal brain CSNK1E.d 174 to 969 791 to 1       791/867
(91 %)
29 diff
(96.7 %id)
BI522577 brain CSNK1E.d 175 to 890 1 to 710       710/710
(100 %)
26 diff
(96.4 %id)
BG491421 amelanotic melanoma, cell line, skin CSNK1E.d 176 to 921 1 to 746   fully sequenced,   746/746
(100 %)
1 diff
(99.9 %id)
BM556143 amelanotic melanoma, cell line, skin CSNK1E.d 177 to 849 1 to 687       687/1487
(46 %)
24 diff
(98.4 %id)
BM423557 amelanotic melanoma, cell line, skin CSNK1E.d 177 to 1131 1 to 971       971/1073
(90 %)
30 diff
(97.3 %id)
BG340173 leiomyosarcoma cell line, uterus CSNK1E.d 182 to 983 1 to 803       803/817
(98 %)
33 diff
(96.0 %id)
BM546123 ovary (pool of 3) CSNK1E.d 184 to 1220 15 to 1057       1043/1129
(92 %)
21 diff
(98.2 %id)
BG910433 anaplastic oligodendroglioma with 1p/19qloss, brain CSNK1E.d 187 to 955 7 to 778       772/779
(99 %)
12 diff
(98.5 %id)
CD723589 eye, lacrimal gland CSNK1E.d 190 to 829 1 to 640       640/640
(100 %)
0 diff
(100 %id)
CR601194 Neuroblastoma Cot 25-normalized CSNK1E.d 192 to 1542 1 to 1351       1351/1351
(100 %)
0 diff
(100 %id)
BX375685 Neuroblastoma Cot 25-normalized CSNK1E.d 192 to 991 1 to 798   fully sequenced,   798/798
(100 %)
7 diff
(99.2 %id)
BY795320 eye CSNK1E.d 194 to 1047 1 to 854       854/854
(100 %)
0 diff
(100 %id)
BU509736 leiomyosarcoma, uterus CSNK1E.d 196 to 1006 1 to 816       816/884
(92 %)
11 diff
(98.8 %id)
CN368316 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CSNK1E.d 197 to 704 1 to 508       508/508
(100 %)
0 diff
(100 %id)
BF127508 leiomyosarcoma cell line, uterus CSNK1E.d 202 to 846 1 to 638       638/769
(82 %)
18 diff
(97.7 %id)
BQ232574 melanotic melanoma, skin CSNK1E.d 203 to 748 1 to 550       550/857
(64 %)
10 diff
(98.9 %id)
BX377593 Placenta Cot 25-normalized CSNK1E.d 207 to 1262 1 to 1057       1057/1057
(100 %)
9 diff
(99.2 %id)
AL134722 brain CSNK1E.d 218 to 813 1 to 595       595/595
(100 %)
1 diff
(99.9 %id)
CR596620 Neuroblastoma Cot 50-normalized CSNK1E.d 233 to 1613 1 to 1381 exact     1381/1381
(100 %)
0 diff
(100 %id)
BX355470 Neuroblastoma Cot 50-normalized CSNK1E.d 233 to 1360 1 to 1121       1121/1130
(99 %)
20 diff
(98.3 %id)
DN997635 breast cancer, Mammary gland (cancer tissue) CSNK1E.d 234 to 945 8 to 719       712/719
(99 %)
0 diff
(100 %id)
DA622053 Kidney CSNK1E.d 238 to 632 139 to 533   capped   395/532
(74 %)
0 diff
(100 %id)
BX346554 Neuroblastoma Cot 50-normalized CSNK1E.d 241 to 969 728 to 6       723/736
(98 %)
14 diff
(98.1 %id)
BX345229 Neuroblastoma Cot 25-normalized CSNK1E.d 247 to 515 1 to 269       269/369
(72 %)
7 diff
(98.2 %id)
BX355359 Neuroblastoma Cot 50-normalized CSNK1E.d 247 to 1213 1 to 965       965/1061
(90 %)
7 diff
(99.4 %id)
BX403460 Neuroblastoma Cot 50-normalized CSNK1E.d 247 to 1208 1 to 963       963/963
(100 %)
3 diff
(99.7 %id)
BU168321 melanotic melanoma, cell line, skin CSNK1E.d 247 to 1060 1 to 821       821/894
(91 %)
10 diff
(98.9 %id)
BU157623 melanotic melanoma, cell line, skin CSNK1E.d 247 to 901 1 to 664       664/967
(68 %)
11 diff
(98.9 %id)
BI549493 brain, hippocampus CSNK1E.d 248 to 515 1 to 268       268/268
(100 %)
4 diff
(98.6 %id)
TI_44169315   CSNK1E.d 249 to 1059 123 to 930       808/1030
(78 %)
4 diff
(99.7 %id)
AB091043   CSNK1E.d 250 to 1629 1 to 1381 exact AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 1381/1381
(100 %)
8 diff
(99.5 %id)
BG339646 leiomyosarcoma cell line, uterus CSNK1E.d 256 to 1019 1 to 768       768/1108
(69 %)
13 diff
(98.9 %id)
DA783391 brain CSNK1E.d 257 to 837 2 to 583   capped   582/583
(99 %)
2 diff
(99.7 %id)
BC006490 Lung, small cell carcinoma CSNK1E.d 260 to 1629 1 to 1370 exact available from MGC, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 1370/1370
(100 %)
0 diff
(100 %id)
BE798466 lung, small cell carcinoma CSNK1E.d 264 to 1065 27 to 832       806/1033
(78 %)
14 diff
(98.7 %id)
CN368315 embryonic stem cells, DMSO-treated H9 cellline CSNK1E.d 274 to 852 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
ES310111 scalp interfollicular dermis, skin CSNK1E.d 276 to 711 1 to 438       438/438
(100 %)
3 diff
(99.4 %id)
BE792763 lung, small cell carcinoma CSNK1E.d 281 to 1038 1 to 756       756/756
(100 %)
2 diff
(99.8 %id)
BX453017 placenta CSNK1E.d 288 to 1131 1 to 844       844/844
(100 %)
11 diff
(98.7 %id)
BG674632 skin CSNK1E.d 296 to 1057 1 to 772       772/772
(100 %)
18 diff
(97.7 %id)
BG491977 amelanotic melanoma, cell line, skin CSNK1E.d 859 to 1553 731 to 35   fully sequenced,   695/729
(95 %)
5 diff
(99.4 %id)
BX332713 Neuroblastoma Cot 25-normalized CSNK1E.d 860 to 1575 713 to 1   fully sequenced,   713/713
(100 %)
5 diff
(99.3 %id)
BX394691 Neuroblastoma Cot 25-normalized CSNK1E.d 860 to 1601 741 to 1   fully sequenced,   741/741
(100 %)
1 diff
(99.9 %id)
BX375684 Neuroblastoma Cot 25-normalized CSNK1E.d 961 to 1542 580 to 1   fully sequenced,   580/580
(100 %)
8 diff
(98.7 %id)
BX387660 Placenta Cot 25-normalized CSNK1E.d 961 to 1603 646 to 5   fully sequenced,   642/646
(99 %)
4 diff
(99.4 %id)
BF726122 eye, lens CSNK1E.d 1406 to 1629 245 to 22   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 224/224
(100 %)
1 diff
(99.6 %id)
AB024597   CSNK1E.e 1 to 1415 1 to 1415 exact tiling clone, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 1415/1415
(100 %)
0 diff
(100 %id)
NM_001894.4   CSNK1E.e 1 to 2641 1 to 2641 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2641/2641
(100 %)
0 diff
(100 %id)
CR456429   CSNK1E.e 99 to 1459 1 to 1358 exact     1358/1358
(100 %)
7 diff
(99.5 %id)
L37043   CSNK1E.e 99 to 1417 10 to 1328 exact     1320/1331
(99 %)
3 diff
(99.8 %id)
AA150308 uterus CSNK1E.e 303 to 726 1 to 422       422/422
(100 %)
10 diff
(97.7 %id)
BU069746 insulinoma, Pancreas CSNK1E.e 528 to 1027 1 to 500   fully sequenced,   500/500
(100 %)
3 diff
(99.4 %id)
BU682883 lung CSNK1E.e 630 to 1433 801 to 1       801/801
(100 %)
7 diff
(99.2 %id)
AI553819 anaplastic oligodendroglioma, brain CSNK1E.e 642 to 1415 772 to 1       774/780
(99 %)
24 diff
(97.0 %id)
BX388227 Neuroblastoma Cot 25-normalized CSNK1E.e 678 to 1438 760 to 1   tiling clone,   760/894
(85 %)
9 diff
(99.0 %id)
TI_149286797   CSNK1E.e 678 to 1437 807 to 56       752/1214
(61 %)
25 diff
(98.0 %id)
BX367467 Neuroblastoma Cot 50-normalized CSNK1E.e 697 to 1438 1 to 743       743/922
(80 %)
10 diff
(99.0 %id)
AI828030 pooled CSNK1E.e 697 to 1417 721 to 1       721/721
(100 %)
9 diff
(98.8 %id)
CA443966 Fibrosarcoma CSNK1E.e 708 to 1433 725 to 1       725/740
(97 %)
4 diff
(99.5 %id)
BQ018664 lung, Metastatic Chondrosarcoma CSNK1E.e 713 to 1433 720 to 1       720/720
(100 %)
3 diff
(99.6 %id)
TI_149273794   CSNK1E.e 722 to 1436 782 to 70       713/948
(75 %)
1 diff
(99.9 %id)
TI_149289431   CSNK1E.e 722 to 1439 771 to 55       717/771
(92 %)
4 diff
(99.5 %id)
AI033792 liver and spleen CSNK1E.e 734 to 1417 684 to 1       684/691
(98 %)
8 diff
(98.9 %id)
AI811332 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors CSNK1E.e 746 to 1427 682 to 1       682/683
(99 %)
10 diff
(98.6 %id)
BM989377 Fibrosarcoma CSNK1E.e 749 to 1433 685 to 1       685/685
(100 %)
0 diff
(100 %id)
BM968226 lung, Primary Lung Epithelial Cells CSNK1E.e 749 to 1433 683 to 1       683/683
(100 %)
2 diff
(99.8 %id)
BF530645 anaplastic oligodendroglioma with 1p/19qloss, brain CSNK1E.e 750 to 1416 18 to 683   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 666/685
(97 %)
7 diff
(99.0 %id)
BU681597 lung CSNK1E.e 751 to 1433 683 to 1       683/683
(100 %)
1 diff
(99.9 %id)
CA413857 Chondrosarcoma Grade II, Left Pelvis CSNK1E.e 758 to 1433 674 to 1       674/674
(100 %)
2 diff
(99.8 %id)
AA737996 pooled germ cell tumors CSNK1E.e 772 to 1417 644 to 1       644/644
(100 %)
9 diff
(98.7 %id)
CR625738 fetal brain CSNK1E.e 780 to 1415 1 to 636   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 636/636
(100 %)
0 diff
(100 %id)
AA402270 ovarian tumor, ovary CSNK1E.e 787 to 1415 628 to 1       628/628
(100 %)
4 diff
(99.4 %id)
BQ188810 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid CSNK1E.e 790 to 1440 1 to 646   fully sequenced,   646/646
(100 %)
5 diff
(99.3 %id)
TI_151733159   CSNK1E.e 790 to 1440 696 to 53       644/1017
(63 %)
2 diff
(99.9 %id)
BQ433676 melanotic melanoma, skin CSNK1E.e 797 to 1415 12 to 630   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 619/630
(98 %)
0 diff
(100 %id)
TI_149294730   CSNK1E.e 819 to 1489 724 to 58   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 667/929
(71 %)
6 diff
(99.4 %id)
BU683364 lung CSNK1E.e 819 to 1489 685 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 667/676
(98 %)
6 diff
(99.2 %id)
AW589825 pooled germ cell tumors CSNK1E.e 820 to 1418 599 to 1       599/599
(100 %)
3 diff
(99.5 %id)
BF983596 duodenal adenocarcinoma, cell line, small intestine CSNK1E.e 830 to 1430 1 to 604       604/604
(100 %)
6 diff
(99.1 %id)
AI421429 brain, glioblastoma (pooled) CSNK1E.e 843 to 1416 574 to 1       574/682
(84 %)
4 diff
(99.5 %id)
BF434326 fibrotheoma, ovary CSNK1E.e 865 to 1415 551 to 1       551/551
(100 %)
0 diff
(100 %id)
DB332038 small intestine CSNK1E.e 872 to 1415 544 to 1       544/544
(100 %)
0 diff
(100 %id)
CR622448 Neuroblastoma Cot 25-normalized CSNK1E.e 900 to 1415 1 to 516   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 516/516
(100 %)
0 diff
(100 %id)
BX328479 Neuroblastoma Cot 25-normalized CSNK1E.e 900 to 1438 539 to 1       539/539
(100 %)
1 diff
(99.9 %id)
BU681072 lung CSNK1E.e 902 to 1433 528 to 1       528/528
(100 %)
4 diff
(99.3 %id)
AI081159 pooled germ cell tumors CSNK1E.e 926 to 1416 491 to 1       491/492
(99 %)
2 diff
(99.6 %id)
AI160966 heart CSNK1E.e 931 to 1417 487 to 1       487/487
(100 %)
2 diff
(99.6 %id)
AI160016 uterus CSNK1E.e 946 to 1416 471 to 1       471/471
(100 %)
1 diff
(99.8 %id)
BF056111 pooled CSNK1E.e 955 to 1420 466 to 1       466/466
(100 %)
0 diff
(100 %id)
AI161299 brain, glioblastoma (pooled) CSNK1E.e 958 to 1416 459 to 1       459/459
(100 %)
0 diff
(100 %id)
CK301174 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid CSNK1E.e 966 to 1433 466 to 1   fully sequenced,   468/468
(100 %)
5 diff
(99.0 %id)
BF003047 Prostate CSNK1E.e 968 to 1415 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AI301919 2 pooled tumors (clear cell type), Kidney CSNK1E.e 969 to 1420 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AW169899 pooled CSNK1E.e 970 to 1418 449 to 1       449/449
(100 %)
2 diff
(99.6 %id)
BU069522 insulinoma, Pancreas CSNK1E.e 972 to 1435 464 to 1   fully sequenced,   464/464
(100 %)
0 diff
(100 %id)
AA152306 uterus CSNK1E.e 973 to 1416 441 to 1       441/441
(100 %)
5 diff
(98.9 %id)
AI366500 brain, meningioma CSNK1E.e 982 to 1420 439 to 1       439/439
(100 %)
2 diff
(99.6 %id)
BP386104 pancreatic islet CSNK1E.e 994 to 1420 1 to 426     Submitted on the opposite strand 426/426
(100 %)
1 diff
(99.8 %id)
AI433171 poorly differentiated adenocarcinoma withsignet ring cell features, stomach CSNK1E.e 997 to 1420 423 to 1       423/423
(100 %)
1 diff
(99.8 %id)
AI968610 pooled germ cell tumors CSNK1E.e 997 to 1416 420 to 1       420/420
(100 %)
0 diff
(100 %id)
BG057967 dorsal root ganglia CSNK1E.e 1066 to 1422 357 to 1       357/357
(100 %)
0 diff
(100 %id)
BE328321 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney CSNK1E.e 1075 to 1420 346 to 1       346/346
(100 %)
0 diff
(100 %id)
AI581674 brain, oligodendroglioma CSNK1E.e 1084 to 1416 333 to 1       333/333
(100 %)
0 diff
(100 %id)
AI692927 pooled CSNK1E.e 1088 to 1418 331 to 1       331/331
(100 %)
0 diff
(100 %id)
AI709337 aorta CSNK1E.e 1105 to 1417 313 to 1       313/313
(100 %)
3 diff
(99.1 %id)
BG033119 breast, mammary adenocarcinoma, cell line CSNK1E.e 1117 to 1402 1 to 286       286/286
(100 %)
0 diff
(100 %id)
AI241909 brain, tumor, 5 pooled (see description) CSNK1E.e 1127 to 1420 295 to 1       295/296
(99 %)
1 diff
(99.7 %id)
AW590067 pooled germ cell tumors CSNK1E.e 1212 to 1416 205 to 1       205/205
(100 %)
0 diff
(100 %id)
AI886952 anaplastic oligodendroglioma, brain CSNK1E.e 1218 to 1456 237 to 1       237/238
(99 %)
1 diff
(99.6 %id)
BU517079 leiomyosarcoma, uterus CSNK1E.e 1261 to 1944 13 to 689       677/702
(96 %)
5 diff
(99.3 %id)
CN264981 embryonic stem cells, cell lines H1, H7, andH9 CSNK1E.e 1328 to 1943 10 to 623   tiling clone,   623/624
(99 %)
3 diff
(99.6 %id)
AI591325 brain, tumor, 5 pooled (see description) CSNK1E.e 1342 to 1422 81 to 1       81/81
(100 %)
0 diff
(100 %id)
BF969977 adrenal cortex carcinoma, cell line, adrenal gland CSNK1E.e 1366 to 2117 1 to 743       743/876
(84 %)
20 diff
(97.8 %id)
BU608548 Human Lung Epithelial cells, lung CSNK1E.e 1399 to 1782 6 to 388     Submitted on the opposite strand 383/397
(96 %)
6 diff
(98.5 %id)
BX095111 eye, retina CSNK1E.e 1409 to 1942 1 to 534       534/534
(100 %)
2 diff
(99.7 %id)
N72515 liver and spleen CSNK1E.e 1413 to 1681 1 to 267       267/269
(99 %)
4 diff
(98.6 %id)
AA019219 eye, retina CSNK1E.e 1418 to 1707 1 to 289       289/289
(100 %)
4 diff
(98.7 %id)
BP422843 small intestine CSNK1E.e 1441 to 1924 1 to 484     Submitted on the opposite strand 484/484
(100 %)
0 diff
(100 %id)
CK430129 eye, lacrimal gland CSNK1E.e 1441 to 1926 1 to 486       486/486
(100 %)
0 diff
(100 %id)
BQ694030 adipose CSNK1E.e 1461 to 1914 1 to 454       454/454
(100 %)
1 diff
(99.8 %id)
BI870960 adenocarcinoma, cell line, Liver CSNK1E.e 1467 to 2209 1 to 744       744/912
(81 %)
18 diff
(98.1 %id)
TI_57230934   CSNK1E.e 1467 to 2209 56 to 799       744/912
(81 %)
18 diff
(98.1 %id)
CR623072 Neuroblastoma Cot 50-normalized CSNK1E.e 1469 to 2642 1 to 1174   tiling clone,   1174/1174
(100 %)
0 diff
(100 %id)
BI850860 bladder, transitional cell papilloma, cell line CSNK1E.e 1480 to 1941 1 to 462       462/462
(100 %)
0 diff
(100 %id)
BP395650 pancreatic islet CSNK1E.e 1528 to 1861 334 to 1       334/344
(97 %)
0 diff
(100 %id)
BG031409 breast, mammary adenocarcinoma, cell line CSNK1E.e 1533 to 2330 1 to 778       778/838
(92 %)
37 diff
(95.6 %id)
H44343 breast CSNK1E.e 1548 to 1973 1 to 435       435/437
(99 %)
16 diff
(96.4 %id)
N44121 melanocyte CSNK1E.e 1665 to 1904 1 to 239       239/239
(100 %)
1 diff
(99.6 %id)
BM714042 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid CSNK1E.e 1703 to 1951 1 to 249       249/249
(100 %)
0 diff
(100 %id)
BG253415 adenocarcinoma, cell line, Liver CSNK1E.e 1766 to 2547 1 to 779       779/851
(91 %)
26 diff
(97.0 %id)
BC013088 Placenta, choriocarcinoma CSNK1E.e 1845 to 2641 1 to 803   available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 803/803
(100 %)
2 diff
(99.8 %id)
BE545119 cervical carcinoma cell line, cervix CSNK1E.e 1855 to 2529 1 to 661       661/772
(85 %)
30 diff
(96.2 %id)
TI_154066499   CSNK1E.e 1944 to 2537 691 to 99   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 593/593
(100 %)
30 diff
(95.0 %id)
TI_149291041   CSNK1E.e 1949 to 2641 785 to 91   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 695/696
(99 %)
2 diff
(99.8 %id)
CA307467 Alveolar Macrophage, lung CSNK1E.e 1957 to 2641 705 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 687/687
(100 %)
2 diff
(99.8 %id)
BM973793 lung CSNK1E.e 1970 to 2641 690 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 672/675
(99 %)
0 diff
(100 %id)
BM679689.
matches multiple genes
eye, fetal eye CSNK1E.e 1976 to 2635 677 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base), also hits gene peyver 661/709
(93 %)
2 diff
(99.8 %id)
N53557 liver and spleen CSNK1E.e 1991 to 2462 477 to 1       477/477
(100 %)
7 diff
(98.6 %id)
CB136141 Liver CSNK1E.e 1995 to 2552 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
H97710 melanocyte CSNK1E.e 2016 to 2268 1 to 254   fully sequenced,   254/254
(100 %)
0 diff
(100 %id)
N29102 melanocyte CSNK1E.e 2016 to 2373 1 to 361   fully sequenced,   361/361
(100 %)
1 diff
(99.8 %id)
BM674656 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid CSNK1E.e 2017 to 2530 512 to 1       512/512
(100 %)
3 diff
(99.5 %id)
AA699750 liver and spleen CSNK1E.e 2034 to 2461 426 to 1       426/426
(100 %)
2 diff
(99.6 %id)
N49326 liver and spleen CSNK1E.e 2037 to 2463 426 to 1       426/427
(99 %)
5 diff
(98.9 %id)
BM795181 stomach CSNK1E.e 2062 to 2638 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
BQ269348 Pancreas, Purified pancreatic islet CSNK1E.e 2076 to 2600 1 to 524       524/524
(100 %)
1 diff
(99.9 %id)
CN291531 embryonic stem cells, DMSO-treated H9 cellline CSNK1E.e 2088 to 2393 1 to 306       306/306
(100 %)
0 diff
(100 %id)
AA359686 lung CSNK1E.e 2103 to 2336 1 to 235       235/235
(100 %)
2 diff
(99.2 %id)
AI199929 placenta CSNK1E.e 2108 to 2520 412 to 1       412/412
(100 %)
1 diff
(99.8 %id)
BM312274 Pancreas, Purified pancreatic islet CSNK1E.e 2126 to 2600 1 to 474       474/474
(100 %)
1 diff
(99.8 %id)
N36115 melanocyte CSNK1E.e 2132 to 2642 510 to 1       510/510
(100 %)
5 diff
(99.1 %id)
AI479996 anaplastic oligodendroglioma, brain CSNK1E.e 2180 to 2641 480 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 463/463
(100 %)
2 diff
(99.6 %id)
DB570899 hypothalamus CSNK1E.e 2195 to 2641 1 to 448   AAA Submitted on the opposite strand 448/448
(100 %)
1 diff
(99.8 %id)
BM725238 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid CSNK1E.e 2199 to 2519 1 to 320   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 320/320
(100 %)
1 diff
(99.7 %id)
H96975 melanocyte CSNK1E.e 2204 to 2641 437 to 1       437/437
(100 %)
4 diff
(99.1 %id)
AI299672 carcinoid, lung CSNK1E.e 2211 to 2640 430 to 1       430/430
(100 %)
0 diff
(100 %id)
BM710437 eye, RPE and Choroid CSNK1E.e 2230 to 2636 1 to 406       406/406
(100 %)
1 diff
(99.8 %id)
H96779 melanocyte CSNK1E.e 2238 to 2643 408 to 1   fully sequenced,   408/408
(100 %)
7 diff
(98.3 %id)
BE670776 carcinoid, lung CSNK1E.e 2242 to 2642 403 to 3       401/403
(99 %)
0 diff
(100 %id)
AI193268 lung CSNK1E.e 2271 to 2642 373 to 1       373/373
(100 %)
1 diff
(99.8 %id)
BM542195 melanotic melanoma, skin CSNK1E.e 2281 to 2641 1 to 360   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 360/360
(100 %)
1 diff
(99.8 %id)
AA019220 eye, retina CSNK1E.e 2286 to 2642 362 to 6       357/362
(98 %)
0 diff
(100 %id)
FN083210 breast carcinoma CSNK1E.e 2327 to 2377 50 to 1     Submitted on the opposite strand 50/50
(100 %)
0 diff
(100 %id)
N21145 melanocyte CSNK1E.e 2343 to 2646 312 to 6   fully sequenced,   307/312
(98 %)
5 diff
(98.4 %id)
BP395086 pancreatic islet CSNK1E.e 2396 to 2638 1 to 243     Submitted on the opposite strand 243/244
(99 %)
1 diff
(99.6 %id)
H44344 breast CSNK1E.e 2441 to 2630 190 to 1       190/190
(100 %)
1 diff
(99.5 %id)
AW662043 colon, moderately-differentiated adenocarcinoma CSNK1E.e 2444 to 2635 206 to 15   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 192/192
(100 %)
0 diff
(100 %id)
AI461440 retina CSNK1E.e 2556 to 2637 84 to 3       82/84
(97 %)
0 diff
(100 %id)
AK092269   CSNK1E.f 1 to 1770 1 to 1770 S53I D305N tiling clone, available from FLJ,   1770/1770
(100 %)
2 diff
(99.9 %id)
BX325424 Neuroblastoma Cot 25-normalized CSNK1E.f 84 to 1014 1 to 931       929/943
(98 %)
33 diff
(96.6 %id)
AA351934 brain CSNK1E.f 166 to 319 1 to 154       154/154
(100 %)
1 diff
(99.4 %id)
BG252976 adenocarcinoma, cell line, Liver CSNK1E.f 454 to 1206 7 to 768       762/843
(90 %)
19 diff
(97.8 %id)
TI_44184873   CSNK1E.f 454 to 1031 166 to 737       572/737
(77 %)
11 diff
(98.6 %id)
H55078   CSNK1E.f 455 to 542 1 to 88       88/88
(100 %)
0 diff
(100 %id)
BM459275 lymph, lymphoma, cell line CSNK1E.f 455 to 1258 1 to 817       817/998
(81 %)
15 diff
(98.5 %id)
CF131517 Chondrosarcoma Lung Metastasis cell lines, lung CSNK1E.f 455 to 1178 1 to 723       723/723
(100 %)
13 diff
(98.3 %id)
CU013278 Synthetic constructs CSNK1E.f 456 to 1714 9 to 1267       1259/1282
(98 %)
6 diff
(99.6 %id)
CU012990 Synthetic constructs CSNK1E.f 456 to 1717 9 to 1270 exact     1262/1285
(98 %)
6 diff
(99.6 %id)
BI116203 lung, small cell carcinoma CSNK1E.f 461 to 1324 1 to 872       872/872
(100 %)
28 diff
(96.8 %id)
TI_1948126816   CSNK1E.f 466 to 1144 128 to 807       680/1121
(60 %)
25 diff
(97.8 %id)
TI_1948126817   CSNK1E.f 466 to 1202 130 to 869       740/1332
(55 %)
24 diff
(98.2 %id)
TI_1948127131   CSNK1E.f 466 to 1113 125 to 777       653/1197
(54 %)
10 diff
(99.2 %id)
TI_1948127132   CSNK1E.f 466 to 1396 130 to 1073       942/1289
(73 %)
30 diff
(97.7 %id)
TI_1948127453   CSNK1E.f 466 to 1030 126 to 688       563/1089
(51 %)
14 diff
(98.8 %id)
TI_1948127454   CSNK1E.f 466 to 1359 130 to 1033       904/1274
(70 %)
20 diff
(98.5 %id)
TI_1948127756   CSNK1E.f 466 to 1152 127 to 807       681/1097
(62 %)
33 diff
(97.0 %id)
BT019831   CSNK1E.f 467 to 1715 1 to 1249       1249/1251
(99 %)
1 diff
(100.0 %id)
CV026774 mixed CSNK1E.f 467 to 1097 1 to 631       631/631
(100 %)
0 diff
(100 %id)
AI272279 brain, oligodendroglioma CSNK1E.f 467 to 730 264 to 1       264/264
(100 %)
1 diff
(99.7 %id)
BM019198 astrocytoma grade IV, cell line, brain CSNK1E.f 471 to 1237 1 to 767       767/767
(100 %)
2 diff
(99.8 %id)
TI_59389878   CSNK1E.f 472 to 1237 133 to 898       766/766
(100 %)
1 diff
(99.9 %id)
BF149225 skin CSNK1E.f 492 to 932 441 to 1       441/441
(100 %)
0 diff
(100 %id)
BM009974 amelanotic melanoma, cell line, skin CSNK1E.f 498 to 1250 1 to 754       754/754
(100 %)
3 diff
(99.7 %id)
BU160976 melanotic melanoma, skin CSNK1E.f 498 to 1350 1 to 867       867/913
(94 %)
24 diff
(97.4 %id)
BM807460 amelanotic melanoma, cell line, skin CSNK1E.f 499 to 1202 25 to 736       712/1072
(66 %)
28 diff
(97.4 %id)
TI_59384763   CSNK1E.f 499 to 1250 52 to 804       753/753
(100 %)
2 diff
(99.8 %id)
AA402705.
matches multiple genes
ovarian tumor, ovary CSNK1E.f 507 to 1106 1 to 599     also hits gene MDK 599/599
(100 %)
7 diff
(98.9 %id)
BM541341 leiomyosarcoma, uterus CSNK1E.f 511 to 1354 1 to 845       845/1064
(79 %)
12 diff
(98.9 %id)
CX870840 embryonic stem CSNK1E.f 529 to 924 1 to 396       396/396
(100 %)
2 diff
(99.5 %id)
CR609912 T cells (Jurkat cell line) Cot10-normalized CSNK1E.f 543 to 1770 1 to 1229   tiling clone, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 1229/1229
(100 %)
1 diff
(100.0 %id)
BX388334 Neuroblastoma Cot 10-normalized CSNK1E.f 543 to 1274 730 to 1       730/730
(100 %)
29 diff
(96.1 %id)
BX340485   CSNK1E.f 543 to 1199 1 to 654       654/654
(100 %)
9 diff
(98.7 %id)
BG676490 skin, squamous cell carcinoma CSNK1E.f 547 to 1320 1 to 776       776/777
(99 %)
3 diff
(99.7 %id)
BG282623 adenocarcinoma, cell line, Prostate CSNK1E.f 548 to 1300 1 to 745       743/978
(75 %)
27 diff
(97.3 %id)
BX326779 Neuroblastoma Cot 25-normalized CSNK1E.f 549 to 1181 1 to 632       632/632
(100 %)
37 diff
(94.2 %id)
CD516127 White Matter CSNK1E.f 551 to 1324 26 to 814       789/987
(79 %)
32 diff
(96.8 %id)
BF346161 anaplastic oligodendroglioma with 1p/19qloss, brain CSNK1E.f 552 to 1352 1 to 785       785/960
(81 %)
15 diff
(98.5 %id)
BI832218 brain, medulla CSNK1E.f 556 to 1370 35 to 845       811/845
(95 %)
0 diff
(100 %id)
TI_57172569   CSNK1E.f 556 to 1370 35 to 845       811/845
(95 %)
0 diff
(100 %id)
BE727584 melanotic melanoma, skin CSNK1E.f 588 to 1352 1 to 761       763/809
(94 %)
22 diff
(97.3 %id)
AW368711 head_neck CSNK1E.f 597 to 857 1 to 261       261/261
(100 %)
1 diff
(99.7 %id)
DB238244 trachea CSNK1E.f 626 to 1202 2 to 578   capped   577/578
(99 %)
0 diff
(100 %id)
BG036648 adenocarcinoma, cell line, Prostate CSNK1E.f 636 to 1421 1 to 787       785/866
(90 %)
17 diff
(98.1 %id)
BX346518   CSNK1E.f 651 to 1544 1 to 889       889/1006
(88 %)
43 diff
(95.8 %id)
TI_57192634   CSNK1E.f 651 to 1368 57 to 774       718/718
(100 %)
4 diff
(99.5 %id)
BI861527 breast, mammary adenocarcinoma, cell line CSNK1E.f 652 to 1368 1 to 717       717/717
(100 %)
4 diff
(99.5 %id)
BX388293 Neuroblastoma Cot 25-normalized CSNK1E.f 653 to 1545 1 to 885       885/1000
(88 %)
31 diff
(96.9 %id)
TI_1948127455   CSNK1E.f 655 to 1716 1190 to 127       1064/1263
(84 %)
46 diff
(96.4 %id)
TI_1948127757   CSNK1E.f 655 to 1716 1180 to 127       1054/1243
(84 %)
26 diff
(98.0 %id)
BX113793 uterus CSNK1E.f 659 to 1475 1 to 818       818/818
(100 %)
1 diff
(99.9 %id)
CR990304 T-Lymphocytes CSNK1E.f 663 to 1480 1 to 819       819/819
(100 %)
2 diff
(99.8 %id)
TI_1948126818   CSNK1E.f 668 to 1716 1178 to 126       1053/1270
(82 %)
40 diff
(96.9 %id)
BQ689779 ductal carcinoma, cell line, Pancreas CSNK1E.f 669 to 1498 1 to 836       836/963
(86 %)
8 diff
(99.2 %id)
BG910782 anaplastic oligodendroglioma with 1p/19qloss, brain CSNK1E.f 671 to 1398 1 to 730       730/730
(100 %)
5 diff
(99.4 %id)
CO393457 Chondrosarcoma Lung Metastasis cell lines, lung CSNK1E.f 673 to 1374 8 to 701       694/840
(82 %)
13 diff
(98.5 %id)
CR976683 T-Lymphocytes CSNK1E.f 686 to 1490 1 to 807       807/807
(100 %)
4 diff
(99.6 %id)
CU444112 epidermis CSNK1E.f 690 to 1061 11 to 382       372/397
(93 %)
2 diff
(99.5 %id)
CU452188 epidermis CSNK1E.f 690 to 1309 11 to 630       620/630
(98 %)
2 diff
(99.7 %id)
CU456395 epidermis CSNK1E.f 690 to 1184 11 to 505       495/520
(95 %)
3 diff
(99.5 %id)
CN368318 embryonic stem cells, cell lines H1, H7, andH9 CSNK1E.f 692 to 1395 1 to 704       704/704
(100 %)
1 diff
(99.9 %id)
BG574406 breast, mammary adenocarcinoma, cell line CSNK1E.f 707 to 1416 1 to 710       710/710
(100 %)
0 diff
(100 %id)
BX403459 Neuroblastoma Cot 50-normalized CSNK1E.f 722 to 1737 1007 to 1       1007/1010
(99 %)
18 diff
(98.3 %id)
BI856387 breast, mammary adenocarcinoma, cell line CSNK1E.f 746 to 1581 1 to 832       834/832
(100 %)
8 diff
(99.1 %id)
TI_57190353   CSNK1E.f 746 to 1581 56 to 887       834/832
(100 %)
8 diff
(99.1 %id)
DA795511 brain CSNK1E.f 749 to 1192 2 to 445   capped   444/444
(100 %)
1 diff
(99.8 %id)
BF308128 muscle, rhabdomyosarcoma CSNK1E.f 773 to 1497 1 to 720       720/722
(99 %)
12 diff
(98.4 %id)
TI_149293960   CSNK1E.f 798 to 1770 1043 to 80   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 964/987
(97 %)
29 diff
(97.1 %id)
BQ955134 sciatic nerve CSNK1E.f 799 to 1689 1 to 893       893/920
(97 %)
18 diff
(98.1 %id)
BX367480   CSNK1E.f 802 to 1545 1 to 741       742/858
(86 %)
33 diff
(96.2 %id)
BX375604 Neuroblastoma Cot 25-normalized CSNK1E.f 803 to 1741 936 to 1       936/936
(100 %)
20 diff
(97.9 %id)
BX428290 brain, fetal brain CSNK1E.f 804 to 1741 928 to 1       928/1060
(87 %)
25 diff
(97.7 %id)
BQ688002 ductal carcinoma, cell line, Pancreas CSNK1E.f 810 to 1501 146 to 846       701/864
(81 %)
17 diff
(98.1 %id)
BM474273 leiomyosarcoma, uterus CSNK1E.f 811 to 1738 1 to 936       936/971
(96 %)
16 diff
(98.4 %id)
BX449374 brain, fetal brain CSNK1E.f 822 to 1710 915 to 28       888/915
(97 %)
22 diff
(97.6 %id)
BX368546 Neuroblastoma Cot 25-normalized CSNK1E.f 828 to 1725 1 to 887       887/887
(100 %)
24 diff
(97.3 %id)
TI_1948127133   CSNK1E.f 831 to 1716 1006 to 126       881/1211
(72 %)
11 diff
(99.1 %id)
DA810580 brain CSNK1E.f 837 to 1372 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
TI_57238293   CSNK1E.f 839 to 1729 27 to 922       896/922
(97 %)
9 diff
(99.1 %id)
BI912803 brain CSNK1E.f 841 to 1729 1 to 894       894/894
(100 %)
9 diff
(99.0 %id)
TI_1948127134   CSNK1E.f 844 to 1716 991 to 126       866/1088
(79 %)
27 diff
(97.6 %id)
BX410765 brain, fetal brain CSNK1E.f 847 to 1713 865 to 1       865/865
(100 %)
9 diff
(99.0 %id)
BQ938029 leiomyosarcoma, uterus CSNK1E.f 847 to 1719 29 to 906       878/913
(96 %)
9 diff
(99.1 %id)
TI_1948127456   CSNK1E.f 863 to 1716 974 to 124       851/1083
(78 %)
28 diff
(97.5 %id)
TI_44184767   CSNK1E.f 881 to 1749 26 to 891   fully sequenced,   866/891
(97 %)
13 diff
(98.6 %id)
BI522525 brain CSNK1E.f 885 to 1749 1 to 861   fully sequenced,   861/861
(100 %)
13 diff
(98.5 %id)
BX409456 brain, fetal brain CSNK1E.f 922 to 1599 1 to 675       675/723
(93 %)
12 diff
(98.4 %id)
BX350833 Neuroblastoma Cot 25-normalized CSNK1E.f 926 to 1750 831 to 1       831/850
(97 %)
32 diff
(96.3 %id)
BX449505 brain, fetal brain CSNK1E.f 936 to 1681 1 to 741       741/741
(100 %)
29 diff
(96.1 %id)
BI038255 nervous_tumor CSNK1E.f 968 to 1246 1 to 279       279/279
(100 %)
1 diff
(99.7 %id)
TI_1948127758   CSNK1E.f 970 to 1716 874 to 128       747/1049
(71 %)
11 diff
(99.0 %id)
BQ716107 sympathetic trunk CSNK1E.f 977 to 1678 1 to 711       711/824
(86 %)
25 diff
(97.0 %id)
BE885039 leiomyosarcoma, uterus CSNK1E.f 996 to 1683 1 to 672       672/724
(92 %)
22 diff
(97.0 %id)
BF350415 head_neck CSNK1E.f 998 to 1120 126 to 4       123/129
(95 %)
1 diff
(99.3 %id)
AL134491 brain CSNK1E.f 1009 to 1603 1 to 594       594/594
(100 %)
1 diff
(99.9 %id)
BQ424425 eye, retinoblastoma CSNK1E.f 1017 to 1718 36 to 745       710/935
(75 %)
12 diff
(98.8 %id)
CB130559 Liver CSNK1E.f 1020 to 1405 1 to 386       386/386
(100 %)
1 diff
(99.8 %id)
TI_1948126819   CSNK1E.f 1031 to 1716 814 to 123       692/1104
(62 %)
11 diff
(99.1 %id)
BX407221 brain, fetal brain CSNK1E.f 1032 to 1750 41 to 753   AAA   713/772
(92 %)
15 diff
(98.1 %id)
AA257958 germinal center B cell CSNK1E.f 1065 to 1395 1 to 330   fully sequenced,   330/330
(100 %)
2 diff
(99.4 %id)
BF127687 leiomyosarcoma cell line, uterus CSNK1E.f 1074 to 1727 1 to 650       650/890
(73 %)
14 diff
(98.5 %id)
BX409449 brain, fetal brain CSNK1E.f 1087 to 1749 1 to 663       663/663
(100 %)
7 diff
(99.0 %id)
BX409450 brain, fetal brain CSNK1E.f 1087 to 1747 1 to 664       664/681
(97 %)
18 diff
(97.4 %id)
AW341300 carcinoid, lung CSNK1E.f 1093 to 1712 620 to 1       620/622
(99 %)
11 diff
(98.3 %id)
BG912836 anaplastic oligodendroglioma with 1p/19qloss, brain CSNK1E.f 1112 to 1749 1 to 637       637/682
(93 %)
4 diff
(99.5 %id)
BX418583 brain, fetal brain CSNK1E.f 1135 to 1756 1 to 622   fully sequenced, AAA   622/622
(100 %)
7 diff
(98.9 %id)
DA394552 thalamus CSNK1E.f 1138 to 1702 2 to 566   capped   565/566
(99 %)
1 diff
(99.9 %id)
CK821728 Pancreas, Purified pancreatic islet CSNK1E.f 1156 to 1678 1 to 523     Submitted on the opposite strand 523/523
(100 %)
0 diff
(100 %id)
BM311935 Pancreas, Purified pancreatic islet CSNK1E.f 1193 to 1680 1 to 488       488/488
(100 %)
2 diff
(99.6 %id)
H55323   CSNK1E.f 1203 to 1351 1 to 149       149/149
(100 %)
0 diff
(100 %id)
AJ709382 heart CSNK1E.f 1212 to 1741 1 to 530       530/530
(100 %)
2 diff
(99.7 %id)
AW806797 stomach CSNK1E.f 1239 to 1382 144 to 1       144/144
(100 %)
0 diff
(100 %id)
BE140530 head_neck CSNK1E.f 1239 to 1383 1 to 145       145/145
(100 %)
1 diff
(99.4 %id)
BX375222 Neuroblastoma Cot 25-normalized CSNK1E.f 1255 to 1501 1 to 247       247/247
(100 %)
0 diff
(100 %id)
BX418582 brain, fetal brain CSNK1E.f 1321 to 1749 427 to 1   fully sequenced,   427/427
(100 %)
1 diff
(99.8 %id)
BI523170 brain CSNK1E.f 1321 to 1719 406 to 3   fully sequenced,   404/406
(99 %)
7 diff
(98.3 %id)
TI_44184768   CSNK1E.f 1321 to 1719 406 to 3   fully sequenced,   404/406
(99 %)
7 diff
(98.3 %id)
AA257959 germinal center B cell CSNK1E.f 1365 to 1709 345 to 1   fully sequenced,   345/345
(100 %)
3 diff
(99.2 %id)
AA091671   CSNK1E.f 1508 to 1715 1 to 207       207/210
(98 %)
13 diff
(93.9 %id)
AW894618 nervous_normal CSNK1E.f 1577 to 1734 1 to 159       159/159
(100 %)
6 diff
(96.3 %id)
AW894657 nervous_normal CSNK1E.f 1577 to 1734 1 to 159       159/159
(100 %)
6 diff
(96.3 %id)
BF347112 anaplastic oligodendroglioma with 1p/19qloss, brain CSNK1E.f 1609 to 1770 1 to 162   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 162/162
(100 %)
0 diff
(100 %id)
BX371192 Placenta Cot 25-normalized CSNK1E.f 1772 to 2253 784 to 303   tiling clone,   784/802
(97 %)
38 diff
(95.3 %id)
BX373001 Neuroblastoma Cot 50-normalized CSNK1E.f 1784 to 2253 641 to 169   tiling clone,   634/641
(98 %)
35 diff
(94.6 %id)
AA775409 whole brain CSNK1E.f 2026 to 2253 554 to 327   tiling clone, AAA   542/542
(100 %)
0 diff
(100 %id)
BF512737   CSNK1E.f 2043 to 2168 457 to 332   AAA   440/440
(100 %)
1 diff
(99.8 %id)
BI037292 nervous_tumor CSNK1E.f 2045 to 2231 1 to 185       201/201
(100 %)
5 diff
(97.6 %id)
AI745190 pooled CSNK1E.f 2095 to 2253 481 to 323       475/481
(98 %)
1 diff
(99.8 %id)
AA862627 Kidney CSNK1E.f 2191 to 2253 372 to 310       372/372
(100 %)
1 diff
(99.8 %id)
AI039199   CSNK1E.f 2196 to 2253 377 to 320       372/392
(94 %)
2 diff
(99.5 %id)
BX439289 placenta CSNK1E.g 1 to 988 1 to 977   tiling clone,   977/1020
(95 %)
13 diff
(98.8 %id)
BG338223 leiomyosarcoma cell line, uterus CSNK1E.g 226 to 951 1 to 746   tiling clone,   746/747
(99 %)
41 diff
(94.6 %id)
BX407209 placenta CSNK1E.g 781 to 1593 28 to 830   tiling clone,   803/927
(86 %)
39 diff
(95.8 %id)
BX409285 placenta CSNK1E.g 907 to 1422 1 to 513   tiling clone,   513/515
(99 %)
11 diff
(97.9 %id)
BM800788 melanotic melanoma, skin CSNK1E.g 938 to 1763 36 to 856       821/1073
(76 %)
24 diff
(97.8 %id)
BQ438237 melanotic melanoma, skin CSNK1E.g 1006 to 1659 1 to 657       657/787
(83 %)
10 diff
(98.8 %id)
BE793577 lung, small cell carcinoma CSNK1E.g 1092 to 1889 1 to 804       804/806
(99 %)
25 diff
(96.9 %id)
DA550501   CSNK1E.g 1306 to 1876 2 to 572   tiling clone, capped   571/571
(100 %)
0 diff
(100 %id)
CN264019 embryonic stem cells, cell lines H1, H7, andH9 CSNK1E.g 1391 to 1896 37 to 542       506/542
(93 %)
0 diff
(100 %id)
BP432076   CSNK1E.g 1444 to 1716 1 to 273       273/273
(100 %)
3 diff
(99.0 %id)
BE314754 brain, neuroblastoma CSNK1E.g 1464 to 2141 29 to 708       680/715
(95 %)
16 diff
(97.8 %id)
BE314875 brain, neuroblastoma CSNK1E.g 1469 to 2163 23 to 723       701/749
(93 %)
22 diff
(97.1 %id)
BF314842 brain, neuroblastoma CSNK1E.g 1485 to 2134 1 to 648       648/648
(100 %)
14 diff
(97.9 %id)
BI198980 brain, neuroblastoma CSNK1E.g 1485 to 2268 1 to 794       794/795
(99 %)
48 diff
(94.0 %id)
BG423305 Kidney, renal cell adenocarcinoma CSNK1E.g 1525 to 2203 1 to 680       680/1127
(60 %)
14 diff
(98.8 %id)
AK057067 small intestine CSNK1E.g 1653 to 3502 1 to 1850   tiling clone, available from FLJ,   1850/1850
(100 %)
0 diff
(100 %id)
DA915699 small intestine CSNK1E.g 1654 to 2374 2 to 729   capped   728/781
(93 %)
11 diff
(98.6 %id)
DR003128 fetal brain CSNK1E.g 1951 to 2497 9 to 556       548/556
(98 %)
3 diff
(99.5 %id)
BU584742 colon CSNK1E.g 1975 to 2593 619 to 1       619/623
(99 %)
5 diff
(99.2 %id)
BG170636 hypernephroma, cell line, Kidney CSNK1E.g 1990 to 2751 1 to 762       762/771
(98 %)
16 diff
(98.0 %id)
BX409044 placenta CSNK1E.g 2040 to 2633 632 to 37       596/767
(77 %)
0 diff
(100 %id)
CX783032 human embryonic stem cells CSNK1E.g 2052 to 2806 7 to 761     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 755/761
(99 %)
0 diff
(100 %id)
BX449615 placenta CSNK1E.g 2117 to 2901 784 to 1       784/1018
(77 %)
21 diff
(98.0 %id)
BU585064   CSNK1E.g 2135 to 2570 1 to 438       438/438
(100 %)
4 diff
(99.1 %id)
BG768554 melanotic melanoma, high MDR (cell line), skin CSNK1E.g 2138 to 3043 1 to 917       917/1014
(90 %)
44 diff
(95.7 %id)
BG768393 melanotic melanoma, high MDR (cell line), skin CSNK1E.g 2138 to 2677 1 to 545       545/921
(59 %)
18 diff
(98.1 %id)
BU585065   CSNK1E.g 2139 to 2582 444 to 1       444/444
(100 %)
2 diff
(99.6 %id)
DN999545   CSNK1E.g 2161 to 2713 1 to 553       553/553
(100 %)
4 diff
(99.3 %id)
BU585081   CSNK1E.g 2169 to 2566 1 to 398       398/398
(100 %)
2 diff
(99.5 %id)
BQ367331 placenta_normal CSNK1E.g 2176 to 2586 1 to 415       415/428
(96 %)
21 diff
(95.1 %id)
BE547480 cervical carcinoma cell line, cervix CSNK1E.g 2196 to 2990 1 to 794       794/877
(90 %)
26 diff
(97.1 %id)
BU585063   CSNK1E.g 2211 to 2609 1 to 399       399/399
(100 %)
1 diff
(99.8 %id)
BU584960 lung CSNK1E.g 2225 to 2620 1 to 396       396/396
(100 %)
0 diff
(100 %id)
BU584503 periph blood CSNK1E.g 2313 to 2588 1 to 276       276/276
(100 %)
0 diff
(100 %id)
AI525827 Prostate CSNK1E.g 2334 to 2938 51 to 672       622/913
(68 %)
0 diff
(100 %id)
BU585078   CSNK1E.g 2425 to 2575 151 to 1       151/151
(100 %)
0 diff
(100 %id)
T51370 placenta CSNK1E.g 2427 to 2690 1 to 274       274/367
(74 %)
18 diff
(95.1 %id)
AV746103 Pituitary CSNK1E.g 2433 to 2755 1 to 324       324/389
(83 %)
8 diff
(98.0 %id)
AV746240 Pituitary CSNK1E.g 2434 to 2680 1 to 239       239/248
(96 %)
8 diff
(96.8 %id)
AV746234 Pituitary CSNK1E.g 2436 to 2680 1 to 236       236/244
(96 %)
8 diff
(96.8 %id)
AV746205 Pituitary CSNK1E.g 2439 to 2654 1 to 210       210/222
(94 %)
10 diff
(95.5 %id)
AV746148 Pituitary CSNK1E.g 2442 to 2755 1 to 315       315/382
(82 %)
8 diff
(98.0 %id)
AV746342 Pituitary CSNK1E.g 2442 to 2754 1 to 309       309/312
(99 %)
13 diff
(95.9 %id)
CN311768 embryonic stem cells, cell lines H1, H7, andH9 CSNK1E.g 2446 to 3063 1 to 618       618/618
(100 %)
1 diff
(99.9 %id)
AV746343 Pituitary CSNK1E.g 2448 to 2753 1 to 306       306/321
(95 %)
13 diff
(96.0 %id)
DA249983 brain CSNK1E.g 2466 to 3051 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
AW583157 Islets of Langerhans, Pancreas CSNK1E.g 2490 to 2924 1 to 435       435/435
(100 %)
1 diff
(99.8 %id)
BX453015 placenta CSNK1E.g 2504 to 3485 982 to 1       982/992
(98 %)
23 diff
(97.7 %id)
BX458967 placenta CSNK1E.g 2516 to 3437 929 to 7       923/929
(99 %)
0 diff
(100 %id)
BX454418 placenta CSNK1E.g 2663 to 3477 845 to 26       820/931
(88 %)
0 diff
(100 %id)
BM999831 Fibrosarcoma CSNK1E.g 2818 to 3502 703 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 685/685
(100 %)
0 diff
(100 %id)
BQ001236 lung, Metastatic Chondrosarcoma CSNK1E.g 2819 to 3502 702 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 684/689
(99 %)
4 diff
(99.5 %id)
BQ021507 lung, Metastatic Chondrosarcoma CSNK1E.g 2837 to 3502 684 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 666/666
(100 %)
2 diff
(99.7 %id)
CX782964 human embryonic stem cells CSNK1E.g 2837 to 3501 700 to 36   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 665/665
(100 %)
11 diff
(98.4 %id)
BU630384 cell lines, Chondrosarcoma CSNK1E.g 2841 to 3502 680 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 662/662
(100 %)
0 diff
(100 %id)
BE151985 head_neck CSNK1E.g 2849 to 3086 12 to 249       238/249
(95 %)
6 diff
(97.6 %id)
BE152208 head_neck CSNK1E.g 2849 to 3086 7 to 247       241/247
(97 %)
10 diff
(96.0 %id)
BG991393 head_neck CSNK1E.g 2849 to 3135 296 to 10       287/296
(96 %)
0 diff
(100 %id)
BI060025 uterus_tumor CSNK1E.g 2849 to 3163 316 to 2       315/316
(99 %)
0 diff
(100 %id)
BG031285 breast, mammary adenocarcinoma, cell line CSNK1E.g 2851 to 3502 1 to 653   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 653/653
(100 %)
3 diff
(99.6 %id)
BM796013 Ascites, stomach CSNK1E.g 2853 to 3266 1 to 414       414/414
(100 %)
4 diff
(99.1 %id)
BE152002 head_neck CSNK1E.g 2857 to 3074 217 to 1     Submitted on the opposite strand 217/217
(100 %)
3 diff
(98.7 %id)
BG982583 colon_normal CSNK1E.g 2858 to 3189 1 to 332       332/332
(100 %)
2 diff
(99.4 %id)
BF915924 uterus_tumor CSNK1E.g 2891 to 3235 1 to 345       345/345
(100 %)
0 diff
(100 %id)
CN311767 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 CSNK1E.g 2896 to 3426 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
BE717581 head_neck CSNK1E.g 2915 to 3215 15 to 313       299/325
(92 %)
13 diff
(96.0 %id)
BE818337 breast_normal CSNK1E.g 2927 to 3073 6 to 152       147/163
(90 %)
5 diff
(97.0 %id)
BE818354 breast_normal CSNK1E.g 2929 to 3225 16 to 312       297/314
(94 %)
13 diff
(95.9 %id)
BE830030 lung_tumor CSNK1E.g 2952 to 3215 13 to 273       261/285
(91 %)
7 diff
(97.6 %id)
BE830027 lung_tumor CSNK1E.g 2958 to 3215 1 to 257       257/269
(95 %)
2 diff
(99.3 %id)
BU608144 Human Lung Epithelial cells, lung CSNK1E.g 2979 to 3502 542 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 524/524
(100 %)
0 diff
(100 %id)
AA377477 synovial membrane CSNK1E.g 2986 to 3216 1 to 231       231/231
(100 %)
0 diff
(100 %id)
DB331508 small intestine CSNK1E.g 3062 to 3502 441 to 1       441/444
(99 %)
5 diff
(98.9 %id)
T51255 placenta CSNK1E.g 3118 to 3502 401 to 3       399/466
(85 %)
0 diff
(100 %id)
AK310303 testis CSNK1E.h 1 to 908 2 to 909   tiling clone,   909/909
(100 %)
0 diff
(100 %id)
DC398325 testis CSNK1E.h 1 to 559 2 to 560       560/560
(100 %)
0 diff
(100 %id)
D79870 aorta CSNK1E.h 80 to 345 1 to 266       266/267
(99 %)
1 diff
(99.7 %id)
CB528589 Aveolar Macrophage, lung CSNK1E.h 545 to 1123 627 to 49   AAA   579/604
(95 %)
3 diff
(99.6 %id)
BM702533 eye, human retina CSNK1E.h 769 to 1396 1 to 626   tiling clone, fully sequenced,   626/626
(100 %)
1 diff
(99.9 %id)
BM665248 eye, human retina CSNK1E.h 1335 to 1858 524 to 1   tiling clone, fully sequenced,   524/524
(100 %)
0 diff
(100 %id)
BG488567 large cell carcinoma, lung CSNK1E.i 1 to 699 1 to 699   tiling clone,   699/699
(100 %)
1 diff
(99.9 %id)
BQ942023 sciatic nerve CSNK1E.i 377 to 1193 1 to 824   tiling clone,   824/884
(93 %)
15 diff
(98.4 %id)
BQ711899 Spleen CSNK1E.i 1108 to 1687 1 to 589       589/1073
(54 %)
23 diff
(97.9 %id)
BQ708467 Spleen CSNK1E.i 1108 to 1840 1 to 745   tiling clone,   745/938
(79 %)
35 diff
(96.3 %id)
DA064894 cerebellum CSNK1E.i 1112 to 1683 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA257027 caudate nucleus CSNK1E.i 1157 to 1714 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
BX480131   CSNK1E.i 1207 to 1724 1 to 518       518/518
(100 %)
1 diff
(99.9 %id)
DA062659 cerebellum CSNK1E.i 1221 to 1791 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BF923841 nervous_tumor CSNK1E.i 1228 to 1400 13 to 185       173/185
(93 %)
0 diff
(100 %id)
CB104961 Ascites, stomach CSNK1E.i 1288 to 1532 1 to 245       245/245
(100 %)
5 diff
(98.0 %id)
CN284174 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CSNK1E.i 1415 to 1935 45 to 564   tiling clone,   520/564
(92 %)
0 diff
(100 %id)
AA631554 lung, lung tumor CSNK1E.i 1743 to 2165 423 to 1       423/423
(100 %)
2 diff
(99.6 %id)
BM918479 pooled pancreas and spleen CSNK1E.i 1760 to 2675 1 to 910   tiling clone,   910/922
(98 %)
8 diff
(99.2 %id)
AI961861 adenocarcinoma, Pancreas CSNK1E.i 1804 to 2170 369 to 1       369/369
(100 %)
3 diff
(99.2 %id)
AA897740 pooled CSNK1E.i 1853 to 2163 311 to 1       311/311
(100 %)
4 diff
(98.8 %id)
BM351962 Pancreas, Purified pancreatic islet CSNK1E.i 1943 to 2168 231 to 1       231/231
(100 %)
7 diff
(97.0 %id)
DW449617 Liver CSNK1E.i 2010 to 2190 17 to 201   tiling clone,   185/202
(91 %)
9 diff
(95.6 %id)
AW512039 lymph node, lymphoma, follicular mixed small and largecell CSNK1E.i 2048 to 2170 123 to 1       123/153
(80 %)
1 diff
(99.4 %id)
AI802217 adenocarcinoma, Pancreas CSNK1E.i 2052 to 2163 116 to 5       112/116
(96 %)
0 diff
(100 %id)
CX759955 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass CSNK1E.i 2061 to 2699 38 to 674   tiling clone, Submitted on the opposite strand 637/674
(94 %)
2 diff
(99.8 %id)
BQ068336 brain CSNK1E.j 1 to 763 10 to 785   tiling clone,   776/1049
(73 %)
14 diff
(98.7 %id)
BX281158 brain CSNK1E.j 11 to 448 1 to 438       438/438
(100 %)
0 diff
(100 %id)
TI_159677122   CSNK1E.j 609 to 1601 45 to 1025   tiling clone,   977/1069
(91 %)
35 diff
(96.8 %id)
F12386 brain, total brain CSNK1E.j 709 to 995 1 to 286       286/286
(100 %)
1 diff
(99.7 %id)
BM550614 melanotic melanoma, skin CSNK1E.j 726 to 1647 1 to 922   tiling clone,   922/1105
(83 %)
9 diff
(99.2 %id)
BX331406 Neuroblastoma Cot 10-normalized CSNK1E.j 995 to 1901 1006 to 104       871/1006
(86 %)
28 diff
(97.3 %id)
BQ435247 melanotic melanoma, skin CSNK1E.j 1090 to 1862 1 to 784       784/868
(90 %)
12 diff
(98.7 %id)
TI_149313902   CSNK1E.j 1179 to 2012 935 to 111   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 825/954
(86 %)
17 diff
(98.3 %id)
TI_227715124   CSNK1E.j 1180 to 2012 920 to 98   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 823/990
(83 %)
21 diff
(97.9 %id)
BX367378 Neuroblastoma Cot 10-normalized CSNK1E.j 1193 to 1979 788 to 1       788/788
(100 %)
12 diff
(98.5 %id)
BF526672 brain, glioblastoma with EGFR amplification CSNK1E.j 1227 to 2007 1 to 770   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 770/770
(100 %)
17 diff
(97.8 %id)
BF037480 adenocarcinoma, ovary CSNK1E.j 1247 to 1916 1 to 662       662/671
(98 %)
10 diff
(98.6 %id)
CU449924 epidermis CSNK1E.j 1272 to 1609 1 to 339       339/343
(98 %)
10 diff
(97.1 %id)
BU624112 cell lines, Enchondroma CSNK1E.j 1305 to 2012 723 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 705/705
(100 %)
3 diff
(99.6 %id)
AW192876 adenocarcinoma, Pancreas CSNK1E.j 1324 to 2012 689 to 1       689/689
(100 %)
10 diff
(98.6 %id)
BQ772643 Chondrosarcoma Cell line CSNK1E.j 1324 to 2012 705 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 687/687
(100 %)
4 diff
(99.5 %id)
CD365617 Alveolar Macrophage, lung CSNK1E.j 1344 to 2012 685 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 667/667
(100 %)
5 diff
(99.3 %id)
W19862 parathyroid gland, parathyroid tumor CSNK1E.j 1349 to 1773 1 to 424   fully sequenced,   424/424
(100 %)
13 diff
(97.0 %id)
AW080555 colon, moderately differentiated adenocarcinoma CSNK1E.j 1359 to 2013 656 to 6   tiling clone,   651/764
(85 %)
7 diff
(99.1 %id)
AA335778 epididymis CSNK1E.j 1366 to 1624 1 to 259       259/259
(100 %)
0 diff
(100 %id)
AW965542   CSNK1E.j 1367 to 1810 1 to 444       444/445
(99 %)
6 diff
(98.7 %id)
AA336044 epididymis CSNK1E.j 1430 to 1797 1 to 375       375/376
(99 %)
15 diff
(96.1 %id)
AW965553   CSNK1E.j 1432 to 1733 1 to 302       302/413
(73 %)
8 diff
(98.1 %id)
CB305730 lung, Primary Lung Cystic Fibrosis EpithelialCells CSNK1E.j 1478 to 2012 553 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 535/535
(100 %)
0 diff
(100 %id)
TI_154190524   CSNK1E.j 1493 to 2012 49 to 565       518/522
(99 %)
9 diff
(98.3 %id)
F10003 brain, total brain CSNK1E.j 1731 to 2012 282 to 1       282/282
(100 %)
0 diff
(100 %id)
N90052 parathyroid gland, parathyroid tumor CSNK1E.j 1748 to 2013 270 to 3   fully sequenced,   268/270
(99 %)
0 diff
(100 %id)
CR617099 HeLa cells Cot 25-normalized CSNK1E.k 1 to 1631 1 to 1631 exact tiling clone,   1631/1631
(100 %)
0 diff
(100 %id)
BX371294   CSNK1E.k 610 to 1608 997 to 1       997/997
(100 %)
9 diff
(99.1 %id)
BX368905   CSNK1E.k 829 to 1210 10 to 389       380/389
(97 %)
4 diff
(99.0 %id)
BX352415   CSNK1E.k 853 to 1631 788 to 1       788/819
(96 %)
32 diff
(96.1 %id)
EL947183 eyeball CSNK1E.k 1150 to 1630 7 to 487   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 481/487
(98 %)
0 diff
(100 %id)
BF111915 pooled CSNK1E.k 1179 to 1630 461 to 10       452/461
(98 %)
0 diff
(100 %id)
AW249706.
matches multiple genes
lung, small cell carcinoma CSNK1E.k 1182 to 1632 461 to 11   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base), also hits gene CDC73 451/451
(100 %)
0 diff
(100 %id)
DB531004 hippocampus CSNK1E.k 1188 to 1630 1 to 441     Submitted on the opposite strand 441/441
(100 %)
9 diff
(98.0 %id)
AI222199 pooled CSNK1E.k 1193 to 1630 442 to 5       438/442
(99 %)
0 diff
(100 %id)
CA433436 mixed CSNK1E.k 1200 to 1630 449 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 431/431
(100 %)
0 diff
(100 %id)
AI818753 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors CSNK1E.k 1205 to 1630 428 to 3       426/428
(99 %)
0 diff
(100 %id)
AI244687 Kidney CSNK1E.k 1214 to 1630 421 to 6       416/421
(98 %)
0 diff
(100 %id)
AI887251 serous papillary carcinoma, high grade, 2pooled tumors, uterus CSNK1E.k 1214 to 1629 428 to 13   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 416/416
(100 %)
0 diff
(100 %id)
AW135782   CSNK1E.k 1236 to 1629 411 to 18   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 394/394
(100 %)
0 diff
(100 %id)
BF476693 sympathetic trunk CSNK1E.k 1253 to 1631 385 to 7       379/385
(98 %)
0 diff
(100 %id)
BE928238 colon CSNK1E.k 1266 to 1487 237 to 20       218/239
(91 %)
0 diff
(100 %id)
AI197928 Prostate CSNK1E.k 1271 to 1630 362 to 3       360/362
(99 %)
0 diff
(100 %id)
AI963212 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors CSNK1E.k 1273 to 1631 408 to 50   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 359/366
(98 %)
27 diff
(92.7 %id)
AI685630 Prostate CSNK1E.k 1275 to 1630 358 to 3       356/358
(99 %)
0 diff
(100 %id)
AI685636 Prostate CSNK1E.k 1275 to 1630 358 to 3       356/358
(99 %)
0 diff
(100 %id)
BE673458 Prostate CSNK1E.k 1275 to 1630 358 to 3       356/358
(99 %)
0 diff
(100 %id)
AA932894 Kidney CSNK1E.k 1283 to 1630 353 to 6       348/353
(98 %)
0 diff
(100 %id)
AW251092 lung, small cell carcinoma CSNK1E.k 1284 to 1632 359 to 11   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 349/349
(100 %)
2 diff
(99.5 %id)
BF060935 follicular carcinoma, thyroid CSNK1E.k 1285 to 1630 361 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 346/351
(98 %)
1 diff
(99.8 %id)
AW205200   CSNK1E.k 1298 to 1630 350 to 18   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 333/333
(100 %)
1 diff
(99.7 %id)
BF060938 follicular carcinoma, thyroid CSNK1E.k 1326 to 1630 334 to 29   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 306/307
(99 %)
10 diff
(96.8 %id)
BG236866 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification CSNK1E.k 1360 to 1630 272 to 2       271/272
(99 %)
0 diff
(100 %id)
AA720784 synovial sarcoma CSNK1E.k 1378 to 1631 288 to 35   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 254/254
(100 %)
0 diff
(100 %id)
AI583152 adenocarcinoma, Pancreas CSNK1E.k 1440 to 1630 229 to 39   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 191/191
(100 %)
5 diff
(97.4 %id)
BE677464 dorsal root ganglia CSNK1E.k 1457 to 1630 182 to 9       174/182
(95 %)
0 diff
(100 %id)
AW149338 Kidney, renal cell tumor CSNK1E.k 1474 to 1630 157 to 1       157/157
(100 %)
0 diff
(100 %id)
AI926439 poorly differentiated adenocarcinoma withsignet ring cell features, stomach CSNK1E.k 1502 to 1630 129 to 1       129/135
(95 %)
1 diff
(99.3 %id)
BG325710 Kidney, renal cell adenocarcinoma CSNK1E.l 1 to 462 1 to 461   tiling clone,   461/462
(99 %)
3 diff
(99.4 %id)
BI599627 brain, hypothalamus CSNK1E.l 169 to 511 1 to 343       343/343
(100 %)
5 diff
(98.6 %id)
TI_45212893   CSNK1E.l 174 to 822 89 to 737   tiling clone,   649/737
(88 %)
1 diff
(99.9 %id)
BM450026 melanotic melanoma, skin CSNK1E.l 190 to 887 79 to 780       702/1086
(64 %)
20 diff
(98.2 %id)
BQ431454 melanotic melanoma, skin CSNK1E.l 508 to 1206 11 to 711   tiling clone,   884/892
(99 %)
23 diff
(97.5 %id)
BX417615 placenta CSNK1E.m 1 to 909 1 to 906   tiling clone,   906/906
(100 %)
3 diff
(99.7 %id)
CN368314 embryonic stem cells, cell lines H1, H7, andH9 CSNK1E.m 259 to 831 1 to 573       573/573
(100 %)
8 diff
(98.7 %id)
BG679278 skin, squamous cell carcinoma CSNK1E.m 265 to 980 1 to 715   tiling clone,   715/715
(100 %)
1 diff
(99.9 %id)
BG385593 adenocarcinoma cell line, colon CSNK1E.m 305 to 861 1 to 556       556/556
(100 %)
3 diff
(99.5 %id)
BG386369 adenocarcinoma cell line, colon CSNK1E.m 305 to 882 1 to 588       588/1003
(58 %)
23 diff
(97.8 %id)
CN368319 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CSNK1E.m 331 to 876 1 to 546       546/546
(100 %)
2 diff
(99.7 %id)
DB464628 hippocampus CSNK1E.m 480 to 931 1 to 452   tiling clone,   452/452
(100 %)
1 diff
(99.8 %id)
CR618521 HeLa cells Cot 25-normalized CSNK1E.n 1 to 2095 1 to 2095 exact tiling clone,   2095/2095
(100 %)
0 diff
(100 %id)
BU585011 soft tissue CSNK1E.n 632 to 1201 1 to 570       570/570
(100 %)
6 diff
(99.0 %id)
BX368884   CSNK1E.n 785 to 1265 17 to 497       481/516
(93 %)
11 diff
(97.9 %id)
BX368885   CSNK1E.n 789 to 1363 1 to 575       575/575
(100 %)
13 diff
(97.8 %id)
BX400792   CSNK1E.n 1135 to 2095 962 to 1       962/962
(100 %)
6 diff
(99.4 %id)
BU584453 brain CSNK1E.n 1169 to 1381 1 to 213       213/213
(100 %)
1 diff
(99.6 %id)
D82544   CSNK1E.n 1222 to 1625 1 to 404       404/404
(100 %)
0 diff
(100 %id)
AW797128 uterus CSNK1E.n 1311 to 1559 23 to 271       249/271
(91 %)
0 diff
(100 %id)
R71550 placenta CSNK1E.o 1 to 361 1 to 363   tiling clone,   363/363
(100 %)
7 diff
(98.1 %id)
R79108 placenta CSNK1E.o 1 to 457 1 to 456   tiling clone,   456/457
(99 %)
8 diff
(98.3 %id)
R71496 placenta CSNK1E.o 453 to 817 365 to 1   tiling clone,   365/365
(100 %)
5 diff
(98.7 %id)
DN601832 human embryonic stem cells CSNK1E.o 495 to 1163 1 to 669   tiling clone,   669/669
(100 %)
0 diff
(100 %id)
R79109 placenta CSNK1E.o 556 to 756 201 to 1       201/202
(99 %)
0 diff
(100 %id)
CN265174 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CSNK1E.o 674 to 908 13 to 247       235/247
(95 %)
0 diff
(100 %id)
BI439003 Pancreas, Purified pancreatic islet CSNK1E.p 1 to 548 1 to 552   tiling clone,   552/552
(100 %)
5 diff
(99.1 %id)
CA776013 Pancreas, Purified pancreatic islet CSNK1E.p 2 to 577 1 to 575   tiling clone, fully sequenced,   575/575
(100 %)
8 diff
(98.7 %id)
CA775726 Pancreas, Purified pancreatic islet CSNK1E.p 432 to 594 163 to 1   tiling clone, fully sequenced,   163/163
(100 %)
0 diff
(100 %id)
BU195680 eye, retinoblastoma CSNK1E.q 1 to 508 1 to 509 R119K tiling clone,   509/979
(51 %)
8 diff
(99.2 %id)
DA927946 small intestine CSNK1E.r 1 to 556 2 to 558 A47C N48Q R49P L50A R51P ... tiling clone, capped   557/557
(100 %)
2 diff
(99.7 %id)
AW130391 poorly differentiated adenocarcinoma withsignet ring cell features, stomach CSNK1E.s 1 to 459 461 to 1 P44X S82K D83R L84F A85R ... tiling clone,   461/461
(100 %)
5 diff
(99.0 %id)
AI685228 adenocarcinoma, Pancreas CSNK1E.s 4 to 462 459 to 1   tiling clone,   459/459
(100 %)
0 diff
(100 %id)
CF454082 peripheral nervous system CSNK1E.t-u 1 to 710 22 to 731 V2G T3S tiling clone,   710/893
(79 %)
10 diff
(98.9 %id)
BU584779 brain CSNK1E.t-u 103 to 545 443 to 1       443/443
(100 %)
2 diff
(99.6 %id)
AW994172 breast_normal CSNK1E.t-u 352 to 926 12 to 583   tiling clone,   572/583
(98 %)
0 diff
(100 %id)
BE813393 breast_normal CSNK1E.t-u 580 to 922 348 to 7       342/348
(98 %)
0 diff
(100 %id)
AI867477 Prostate CSNK1E.t-u 731 to 948 218 to 1   tiling clone,   218/218
(100 %)
1 diff
(99.6 %id)
GD151258   CSNK1E.t-u 738 to 866 129 to 1     Submitted on the opposite strand 129/131
(98 %)
2 diff
(98.5 %id)
AK074438 Human lung CSNK1E.t-u 910 to 2939 1 to 2028   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2028/2028
(100 %)
6 diff
(99.8 %id)
CF798455   CSNK1E.t-u 1252 to 1585 34 to 367   tiling clone,   334/367
(91 %)
0 diff
(100 %id)
TI_151700189   CSNK1E.u 1 to 612 695 to 86 F84X tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 610/1010
(60 %)
5 diff
(99.6 %id)
BU585122   CSNK1E.u 187 to 612 17 to 442   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 426/442
(96 %)
0 diff
(100 %id)
R54939 breast CSNK1E.u 195 to 611 423 to 2       422/427
(98 %)
0 diff
(100 %id)
BE349269 malignant melanoma, metastatic to lymphnode, skin CSNK1E.u 216 to 612 412 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 397/398
(99 %)
1 diff
(99.8 %id)
AA694546 parathyroid gland, parathyroid tumor CSNK1E.u 219 to 612 402 to 13   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 390/390
(100 %)
5 diff
(98.8 %id)
AI022854 parathyroid gland, parathyroid tumor CSNK1E.u 223 to 612 403 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 388/388
(100 %)
6 diff
(98.5 %id)
AI954586 malignant melanoma, metastatic to lymphnode, skin CSNK1E.u 224 to 612 401 to 13   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 389/389
(100 %)
0 diff
(100 %id)
AW205949   CSNK1E.u 235 to 612 395 to 18   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 378/378
(100 %)
2 diff
(99.5 %id)
BM069698 Islets of Langerhans, Pancreas CSNK1E.u 329 to 612 1 to 286   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 286/288
(99 %)
8 diff
(97.3 %id)
AA989589 Spleen CSNK1E.u 359 to 613 256 to 4       253/260
(97 %)
0 diff
(100 %id)
BM827293 Ascites, stomach CSNK1E.u 403 to 923 1 to 521   tiling clone,   521/521
(100 %)
1 diff
(99.9 %id)
AL121458 melanoma (MeWo cell line) CSNK1E.u 430 to 782 42 to 394       353/395
(89 %)
1 diff
(99.8 %id)
BE394869 endometrium, adenocarcinoma cell line, uterus CSNK1E.u 473 to 880 1 to 409       409/416
(98 %)
3 diff
(99.3 %id)
DW460897 Liver CSNK1E.u 850 to 964 17 to 133   tiling clone,   117/133
(87 %)
0 diff
(100 %id)
AK124064 synovial membrane tissue from rheumatioidarthritis CSNK1E.va 1 to 1918 1 to 1919 A31G R33A A34R P35A Q36A ... tiling clone, available from FLJ,   1919/1919
(100 %)
2 diff
(99.9 %id)
DA980537 synovial membrane tissue from rheumatioidarthritis CSNK1E.va 1 to 571 2 to 575 P24A E25R Q27A D28R T30D ... capped   574/574
(100 %)
4 diff
(99.4 %id)
DB334871 synovial membrane tissue from rheumatioidarthritis CSNK1E.va 1380 to 1918 539 to 1       539/539
(100 %)
0 diff
(100 %id)
CN411697 embryonic stem cells, cell lines H1, H7, andH9 CSNK1E.vb-u 1 to 754 1 to 754   tiling clone,   754/754
(100 %)
1 diff
(99.9 %id)
AA736932 germinal center B cell CSNK1E.vb-u 417 to 742 378 to 53       326/378
(86 %)
0 diff
(100 %id)
CN269102 embryonic stem cells, DMSO-treated H9 cellline CSNK1E.vb-u 573 to 1057 1 to 485   tiling clone,   485/485
(100 %)
0 diff
(100 %id)
AW995263 breast_normal CSNK1E.vb-u 756 to 1258 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
AW999215 breast_normal CSNK1E.vb-u 910 to 1293 18 to 401   tiling clone,   384/403
(95 %)
4 diff
(99.1 %id)
BF670613 muscle (skeletal) CSNK1E.vb-u 945 to 1580 1 to 642   tiling clone,   642/1461
(43 %)
18 diff
(98.8 %id)
CN275295 embryonic stem cells, DMSO-treated H9 cellline CSNK1E.vb-u 1357 to 2069 8 to 720 exact tiling clone,   713/720
(99 %)
0 diff
(100 %id)
AW972537   CSNK1E.vb-u 1364 to 1936 572 to 1 T10P K15R D16N R19G I20S ...   Submitted on the opposite strand 572/573
(99 %)
10 diff
(98.3 %id)
AA922558 pooled germ cell tumors CSNK1E.vb-u 1525 to 1937 413 to 1       413/413
(100 %)
0 diff
(100 %id)
AI693564 colon CSNK1E.vb-u 1541 to 1934 394 to 1       394/394
(100 %)
0 diff
(100 %id)
AA505925 breast CSNK1E.vb-u 1544 to 1936 393 to 1       393/393
(100 %)
0 diff
(100 %id)
AA927038 pooled germ cell tumors CSNK1E.vb-u 1600 to 1936 337 to 1       337/337
(100 %)
0 diff
(100 %id)
AW612343 Kidney CSNK1E.vb-u 1625 to 2165 541 to 1   tiling clone,   541/541
(100 %)
1 diff
(99.9 %id)
BF980853 duodenal adenocarcinoma, cell line, small intestine CSNK1E.vb-u 2098 to 2764 1 to 674   tiling clone,   674/926
(72 %)
12 diff
(98.8 %id)
CD252185 White Matter CSNK1E.vc-u 1 to 492 26 to 515   tiling clone,   490/1004
(48 %)
30 diff
(97.1 %id)
AA223173 brain, neuroepithelial cells CSNK1E.vc-u 109 to 557 1 to 455       455/455
(100 %)
7 diff
(98.5 %id)
CA778221 Pancreas, Purified pancreatic islet CSNK1E.vc-u 128 to 889 19 to 780       762/780
(97 %)
0 diff
(100 %id)
BF338451 brain, glioblastoma with EGFR amplification CSNK1E.vc-u 167 to 868 1 to 695       695/910
(76 %)
15 diff
(98.4 %id)
CN418905 embryonic stem cells, cell lines H1, H7, andH9 CSNK1E.vc-u 177 to 747 1 to 571   tiling clone,   571/571
(100 %)
2 diff
(99.7 %id)
CN418906 embryonic stem cells, cell lines H1, H7, andH9 CSNK1E.vc-u 210 to 935 1 to 725       725/725
(100 %)
10 diff
(98.7 %id)
BU557731 adenocarcinoma, cell line, breast CSNK1E.vc-u 642 to 1462 17 to 842 V97G T98H tiling clone,   826/1006
(82 %)
21 diff
(98.0 %id)
CB857855 anterior tongue, pooled CSNK1E.vc-u 700 to 1264 1 to 565       565/565
(100 %)
0 diff
(100 %id)
BF757693 colon CSNK1E.vc-u 713 to 965 1 to 264       264/299
(88 %)
15 diff
(95.0 %id)
BE255846 eye, retinoblastoma CSNK1E.vc-u 758 to 1429 1 to 670 F75L P78Q S79V A80Q V81W ...     670/675
(99 %)
11 diff
(98.4 %id)
BQ008872 Chondrosarcoma, Left Pelvis CSNK1E.vc-u 963 to 1639 676 to 1 exact tiling clone,   676/676
(100 %)
1 diff
(99.9 %id)
CA777945 Pancreas, Purified pancreatic islet CSNK1E.vc-u 1011 to 1611 601 to 1 D94K R95K     601/601
(100 %)
9 diff
(98.6 %id)
CK821729 Pancreas, Purified pancreatic islet CSNK1E.vc-u 1074 to 1623 550 to 1     Submitted on the opposite strand 550/550
(100 %)
2 diff
(99.7 %id)
AA223174 brain, neuroepithelial cells CSNK1E.vc-u 1138 to 1597 459 to 1       459/460
(99 %)
4 diff
(99.2 %id)
AW004884 poorly differentiated adenocarcinoma withsignet ring cell features, stomach CSNK1E.vc-u 1178 to 1626 449 to 1       449/449
(100 %)
2 diff
(99.6 %id)
BM311346 Pancreas, Purified pancreatic islet CSNK1E.vc-u 1203 to 1646 451 to 4   tiling clone,   448/451
(99 %)
0 diff
(100 %id)
AW338179 adenocarcinoma, Pancreas CSNK1E.vc-u 1206 to 1627 422 to 1   tiling clone,   422/422
(100 %)
3 diff
(99.3 %id)
AI933658 poorly differentiated adenocarcinoma withsignet ring cell features, stomach CSNK1E.vc-u 1293 to 1626 336 to 1       336/336
(100 %)
4 diff
(98.9 %id)
DR980431 placenta CSNK1E.vc-u 1514 to 1621 1 to 106   AAA Submitted on the opposite strand 106/106
(100 %)
6 diff
(94.4 %id)
DA673668   CSNK1E.vd 1 to 502 2 to 504 exact tiling clone, capped   503/503
(100 %)
1 diff
(99.9 %id)
BI755842 brain CSNK1E.vd 12 to 738 1 to 728 G36C tiling clone,   728/729
(99 %)
10 diff
(98.7 %id)
TI_57216490   CSNK1E.vd 14 to 738 32 to 757 G36C     726/758
(95 %)
8 diff
(99.0 %id)
R57490   CSNK1E.vd 295 to 621 1 to 318       318/324
(98 %)
11 diff
(96.7 %id)
CV414959 breast CSNK1E.vd 612 to 986 373 to 1     Submitted on the opposite strand 373/383
(97 %)
26 diff
(93.3 %id)
BE065635 breast CSNK1E.vd 615 to 930 20 to 331   tiling clone,   312/331
(94 %)
0 diff
(100 %id)
BE065618 breast CSNK1E.vd 626 to 1051 425 to 1   tiling clone, Submitted on the opposite strand 425/434
(97 %)
5 diff
(98.9 %id)
CB118011 brain CSNK1E.vd 796 to 1080 1 to 285   tiling clone,   285/285
(100 %)
1 diff
(99.7 %id)
BE065533 breast CSNK1E.vd 878 to 1008 15 to 142       128/142
(90 %)
0 diff
(100 %id)
AK307225 lung CSNK1E.ve 1 to 1074 2 to 1075 K44R tiling clone,   1075/1075
(100 %)
3 diff
(99.8 %id)
DA594432 lung CSNK1E.ve 1 to 547 2 to 550 K44R capped   549/549
(100 %)
5 diff
(99.1 %id)
BF663488 B-cells, primary B-cells from tonsils (cell line) CSNK1E.vf 1 to 789 1 to 785 P76R C77V L78G G79F S80W ... tiling clone,   785/1128
(69 %)
30 diff
(97.4 %id)
BF974380 B-cells, primary B-cells from tonsils (cell line) CSNK1E.vf 1 to 351 1 to 351 L78Q G88L M91N L92A I93Y ... tiling clone,   881/984
(89 %)
51 diff
(94.9 %id)
BF975887 B-cells, primary B-cells from tonsils (cell line) CSNK1E.vf 1 to 725 1 to 723       723/1029
(70 %)
17 diff
(98.4 %id)
BG398431 B-cells, primary B-cells from tonsils (cell line) CSNK1E.vf 1 to 748 1 to 752 R56E V57*     752/754
(99 %)
22 diff
(97.1 %id)
BG398336 B-cells, primary B-cells from tonsils (cell line) CSNK1E.vf 1 to 768 1 to 773 L78R G79V S80L Q82R G83D ... tiling clone,   773/948
(81 %)
25 diff
(97.4 %id)
BG341568 B-cells, primary B-cells from tonsils (cell line) CSNK1E.vf 1 to 652 1 to 654       654/654
(100 %)
8 diff
(98.8 %id)
BG684753 B-cells, primary B-cells from tonsils (cell line) CSNK1E.vf 1 to 598 1 to 599       599/601
(99 %)
8 diff
(98.7 %id)
BG685413 B-cells, primary B-cells from tonsils (cell line) CSNK1E.vf 1 to 758 1 to 760 G88V C111L P112S L113S S114* tiling clone,   760/760
(100 %)
6 diff
(99.3 %id)
BG753947 B-cells, primary B-cells from tonsils (cell line) CSNK1E.vf 1 to 721 1 to 721       721/722
(99 %)
8 diff
(98.9 %id)
BG759100 B-cells, primary B-cells from tonsils (cell line) CSNK1E.vf 1 to 764 1 to 770 G88V M91N L92A I93Y A94R ... tiling clone,   770/771
(99 %)
16 diff
(98.0 %id)
BG759710 B-cells, primary B-cells from tonsils (cell line) CSNK1E.vf 1 to 561 1 to 561       561/561
(100 %)
2 diff
(99.7 %id)
BG758057 B-cells, primary B-cells from tonsils (cell line) CSNK1E.vf 1 to 738 1 to 739 G88V tiling clone,   739/739
(100 %)
4 diff
(99.5 %id)
BG758849 B-cells, primary B-cells from tonsils (cell line) CSNK1E.vf 1 to 668 1 to 671       671/909
(73 %)
19 diff
(98.0 %id)
BG757920 B-cells, primary B-cells from tonsils (cell line) CSNK1E.vf 1 to 660 1 to 660       660/660
(100 %)
4 diff
(99.4 %id)
BF128809 B-cells, primary B-cells from tonsils (cell line) CSNK1E.vf 21 to 755 1 to 725 R87X G88V G89R L90P M91N ...     725/817
(88 %)
17 diff
(98.0 %id)
BF128747 B-cells, primary B-cells from tonsils (cell line) CSNK1E.vf 21 to 701 1 to 678   tiling clone,   678/678
(100 %)
7 diff
(99.0 %id)
CV346581 uterus CSNK1E.vf 399 to 753 14 to 368       355/368
(96 %)
0 diff
(100 %id)
TI_44346213   CSNK1E.vg 1 to 688 76 to 763 G2R G3A A4G tiling clone,   688/763
(90 %)
3 diff
(99.7 %id)
DB484826 hypothalamus CSNK1E.vg 12 to 457 1 to 449   tiling clone,   449/449
(100 %)
11 diff
(97.6 %id)
TI_44167172   CSNK1E.vh 1 to 633 122 to 754 exact     633/756
(83 %)
17 diff
(97.8 %id)
BI548352 brain, hippocampus CSNK1E.vh 3 to 633 1 to 631 exact tiling clone,   631/633
(99 %)
17 diff
(97.4 %id)
NR_002821.2   CSNK1E.vi 1 to 494 1 to 494   RefSeq, tiling clone,   494/494
(100 %)
0 diff
(100 %id)
DA847599 placenta CSNK1E.vi 55 to 627 2 to 574 T43A S47G tiling clone, capped   573/573
(100 %)
3 diff
(99.5 %id)
CN357790 embryonic stem cells, DMSO-treated H9 cellline CSNK1E.vi 89 to 494 1 to 406       406/406
(100 %)
3 diff
(99.3 %id)
DA510546 brain CSNK1E.vj 1 to 578 2 to 579 exact tiling clone, capped   578/578
(100 %)
1 diff
(99.9 %id)
BX956128   CSNK1E.vk 1 to 468 1 to 468 exact tiling clone,   468/468
(100 %)
0 diff
(100 %id)
DA923607 small intestine CSNK1E.vl-u 1 to 301 2 to 302 exact tiling clone, capped   301/301
(100 %)
3 diff
(99.1 %id)
BF892602 marrow CSNK1E.vm-u 1 to 287 1 to 287 A38S tiling clone,   287/287
(100 %)
1 diff
(99.7 %id)
AA299709 uterus Gene CSNK1E, variant not shown         This clone was ignored    
BE835897 prostate_normal Gene CSNK1E, variant not shown         Suspected internal deletion, this clone was ignored    
BF854664 lung_normal Gene CSNK1E, variant not shown         This clone was ignored    
BI438676 Pancreas, Purified pancreatic islet Gene CSNK1E, variant not shown         This clone was ignored    
BX355358 Neuroblastoma Cot 50-normalized Gene CSNK1E, variant not shown         This clone was ignored    
BX396353 Placenta Cot 25-normalized Gene CSNK1E, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
BX396354 Placenta Cot 25-normalized Gene CSNK1E, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
BX492985   Gene CSNK1E, variant not shown         This clone was ignored    
BX492986   Gene CSNK1E, variant not shown       AAA This clone was ignored    
AA494125 colon Gene CSNK1E, variant not shown       AAA This clone was ignored    
CD580058 brain Gene CSNK1E, variant not shown              
AV745528 Pituitary Gene CSNK1E, variant not shown         This clone was ignored    
AV745572 Pituitary Gene CSNK1E, variant not shown         This clone was ignored    
AV745556 Pituitary Gene CSNK1E, variant not shown         This clone was ignored    
AV745604 Pituitary Gene CSNK1E, variant not shown         This clone was ignored    
AV745699 Pituitary Gene CSNK1E, variant not shown         This clone was ignored    
AV745597 Pituitary Gene CSNK1E, variant not shown         This clone was ignored    
AV745861 Pituitary Gene CSNK1E, variant not shown         This clone was ignored    
AV745913 Pituitary Gene CSNK1E, variant not shown         This clone was ignored    
AV746180 Pituitary Gene CSNK1E, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t-u, .u, .va, .vb-u, .vc-u, .vd, .ve, .vf, .vg, .vh, .vi, .vj, .vk, .vl-u, .vm-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI